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ABSTRACT 
 
Acute kidney injury (AKI) is a devastating potential consequence of renal 
ischaemia and reperfusion (I-R) subsequent to severe intra-operative hypotension 
and fluid resuscitation. Acute tubular epithelial damage is a common early 
histological abnormality in this syndrome. The high mortality rate associated with 
AKI in dogs is attributed in part to the limitations of current diagnostic techniques 
that can only detect AKI in the late stages when damage is irreversible. Early 
detection of renal tubular injury could improve outcome and might be possible by 
measuring urinary neutrophil gelatinase-associated lipocalin concentration 
(uNGAL) in at-risk dogs. 
The objectives of this study were to establish a clinically relevant canine model 
of renal I-R injury, and use this model to determine changes in uNGAL within 
three hours of initiation of injury. 
A pilot study was performed to establish the severity and duration of 
hypotension caused by haemorrhage, and duration of reperfusion, that produced 
histological evidence of acute tubular damage. Urine samples obtained during this 
pilot were used to determine optimal sample dilutions for use with a commercial 
dog NGAL immunoassay. Investigation into potential interference of synthetic 
colloid fluid solutions with the immunoassay was also performed. This 
experimental model was then used to determine changes in uNGAL in seven 
anaesthetised greyhound dogs.  Urinary NGAL concentrations were measured 
before (T0) and immediately following (T1) haemorrhage, and hourly following 
fluid resuscitation (T2 - T4).  After T4, dogs were euthanised, and renal tissue 
collected for histopathology. Statistical analysis for the main study was performed 
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using repeated measures one-way ANOVA and data presented are mean (95% 
confidence interval). 
The pilot study showed that maintenance of mean arterial pressure (MAP) 
below 40 mmHg for one hour (ischaemic phase); followed by fluid resuscitation to 
maintain MAP > 60 mmHg for three hours (reperfusion phase) was required to 
ensure tubular damage was produced. Optimal dilution of urine samples for 
accurate NGAL measurement using the immunoassay was 1 in 1000.  A 4% 
gelatin-based colloid solution did not interfere with the immunoassay. In the main 
study, histopathology confirmed renal tubular epithelial damage in all dogs. Urine 
NGAL increased from a mean of 12.1 (confidence interval 0 – 30.6) ng mL-1 at T0 
to 122.0 (64.1 – 180.0) ng mL-1 by T3. Compared to T0, uNGAL was significantly 
higher at T3 (p = 0.016). Fold change in uNGAL at T3 was 24.2 (7.3 – 41.0). 
Pressure-guided acute haemorrhage followed by colloid resuscitation produced 
a clinically relevant model of I-R AKI in dogs. Despite wide individual variation in 
baseline uNGAL, increases in uNGAL were observed in all dogs suggesting this 
biomarker has potential for detecting early tubular injury caused by renal I-R in 
this species. 
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CHAPTER 1 - LITERATURE REVIEW 
INTRODUCTION 
Acute kidney injury (AKI) is a syndrome that carries a high mortality rate in dogs, 
but unfortunately is difficult to diagnose sufficiently early to allow effective 
treatment. This review will describe the aetiology of AKI, the implications of the 
syndrome in dogs and current diagnostic techniques.  The potential value of new 
diagnostic tests will also be explored. 
ACUTE KIDNEY INJURY IN DOGS 
Acute kidney injury is defined as an abrupt decline in renal function (Mugford et 
al. 2013). Previous terminology used to describe this process included “acute renal 
failure” and “acute tubular necrosis”; however these terms did not reflect that loss 
of kidney function is a multifactorial and dynamic process (Moore 2010; Ross 
2011; Thoen & Kerl 2011). The kidney damage associated with the syndrome 
known as AKI is progressive and may, or may not, lead to renal failure (Thoen & 
Kerl 2011). 
AETIOLOGY  
There are many potential causes of AKI in dogs including ischaemia-reperfusion 
(I-R), nephrotoxicity, inflammation, infection, prolonged urinary tract obstruction, 
and hypercalcaemia (Ross 2011; Mugford et al. 2013).  Ischaemia-reperfusion 
events are thought to be the most common cause of AKI in dogs (Vaden et al. 
1997). Causes of ischaemia include reduced renal perfusion (associated with shock, 
non-steroidal anti-inflammatory drugs, anaesthesia, severe trauma or hypothermia), 
severe hypoxia, systemic inflammatory response syndrome (associated with sepsis, 
multiple organ dysfunction or acute pancreatitis) and vascular abnormalities 
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(including renal vessel thrombosis, disseminated intravascular coagulopathy or 
vasculitis) (Vaden et al. 1997; Mugford et al. 2013).  Given the aetiology, it is 
evident that patients undergoing general anaesthesia or hospitalisation in an 
intensive/critical care setting have an increased risk of developing AKI. 
IMPLICATIONS 
The reported percentage of dogs diagnosed with AKI that do not survive ranges 
from 56 – 65% according to several retrospective studies (Behrend et al. 1996; 
Vaden et al. 1997; Lee et al. 2011; Hsu et al. 2014).  By the time it is diagnosed, 
AKI is associated with a long period of morbidity and therefore a long hospital 
stay. The costs of prolonged hospitalisation and advanced therapeutic options, such 
as peritoneal dialysis or haemodialysis, are large and unfortunately often lead to 
owners opting for euthanasia.  The proportion of dogs diagnosed with AKI that 
were euthanised was 34% in one study and 38% in another (Behrend et al. 1996; 
Vaden et al. 1997).  In dogs that survive, the development of chronic kidney 
disease (CKD) following AKI is common, with a frequency of 50% in one study 
(Vaden et al. 1997). 
FREQUENCY OF ISCHAEMIA-REPERFUSION INDUCED ACUTE 
KIDNEY INJURY 
The importance of an I-R event as a cause of AKI, with or without anaesthesia, has 
been identified in several studies. A previous (within two weeks) episode of 
general anaesthesia was identified as the cause in four of 29 dogs diagnosed with 
“hospital-acquired acute renal failure” in a single hospital over a nine year period 
(Behrend et al. 1996).  However, the occurrence of AKI following anaesthesia in 
that hospital may actually have been much higher than that reported; as the authors 
chose only to diagnose AKI if renal azotaemia was present, possibly resulting in 
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many cases being missed that would fit the current definition of AKI (Behrend et 
al. 1996; Sharfuddin & Molitoris 2011).  
In a separate study, a preceding ischaemic event was identified in more than 50% 
of dogs that developed acute renal failure (Vaden et al. 1997). In that study, acute 
renal failure was diagnosed by clinical signs, azotaemia, renomegaly (as detected 
by abdominal palpation, radiography or ultrasonography) and absence of data 
consistent with chronic renal failure.  
Although not designed to investigate the frequency of canine AKI, a more recent 
veterinary study found that of 12 (30.7%) of 39 healthy dogs undergoing general 
anaesthesia to facilitate a variety of surgeries over a two year period were 
diagnosed with AKI on the basis of a post-operative increase in serum creatinine 
concentration (sCr) (Lee et al. 2012).  Interestingly, dogs diagnosed with AKI had 
a significantly longer duration of general anaesthesia compared to those that did 
not develop AKI. 
The above studies emphasise the importance of I-R as a cause of AKI in dogs. In 
order to develop methods of diagnosis and appropriate treatment, it is important to 
understand how I-R leads to renal damage. The following section outlines the 
pathophysiology of I-R induced renal injury.    
PATHOPHYSIOLOGY OF ISCHAEMIA-REPERFUSION INDUCED 
ACUTE KIDNEY INJURY 
Although often simply referred to as “ischaemic AKI”; it is important to recognise 
that both ischaemia and subsequent reperfusion play a part in the development of 
AKI. During ischaemia there is a critical reduction in delivery of oxygen and other 
nutrients to kidney cells.  Subsequent adenosine triphosphate depletion leads to 
metabolic and structural damage to renal tubular cells, resulting in disrupted kidney 
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function (Bonventre & Yang 2011; Ross 2011; Sharfuddin & Molitoris 2011).  
Reperfusion of the kidney during fluid resuscitation can augment the injury, mainly 
via production of reactive oxygen species (Collard & Gelman 2001). The main 
pathologic and functional abnormalities associated with I-R AKI are reduction in 
glomerular filtration rate (GFR), tubular obstruction, back leakage of filtrate across 
damaged tubular cells and haemodynamic alterations (vasoconstriction and renal 
medullary hypoxia) (Cowgill & Francey 2005). To understand the pathogenesis of 
these abnormalities we must consider the metabolic and structural changes that 
occur on a cellular level, as well as the haemodynamic changes and inflammation 
that occur.  
The renal tubules, along with renal capillaries, comprise the working tissue mass of 
the kidney (Eaton & Pooler 2009). The tubules are responsible for reabsorption and 
secretion of water, solutes and toxins (Eaton & Pooler 2009). The tubules are 
classified into the proximal tubule which drains the glomerulus and runs from the 
cortex of the kidney into the outer medulla, Henle’s loop which consists of a 
descending thin limb, ascending thin limb and ascending thick limb and traverses 
into the inner medulla before travelling back to the cortex, the distal convoluted 
tubule, and finally the connecting tubule which leads to the collecting duct system 
of the nephron (Fig. 1.1) (Eaton & Pooler 2009). 
 18 
 
 
 
 
Figure 1.1 Anatomy of a renal nephron (from: Atherton J.C.  Anaesthesia 
and Intensive Care Medicine 2012 13:7 pp316-319) 
Tubules consist of a single layer of epithelial cells resting on a basement 
membrane. The characteristics of epithelial cells vary depending upon location 
within the tubule and associated function (Cowgill & Francey 2005). The renal 
epithelium is highly specialised in order for the kidney to perform many energy 
dependent active functions. These functions include reabsorption of substances 
from the glomerular filtrate back into the blood, and secretion of substances from 
the blood to the tubular lumen via transcellular or paracellular transport (Cowgill & 
Francey 2005). For example, the epithelium of the proximal tubule contains a brush 
border that provides an increased surface area for improved absorption and 
intracellular transport of substances such as water, sodium and glucose (Clarkson 
& Fletcher 2011).  This high metabolic workload means that the tubular 
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epithelium, particularly in the proximal tubules which have a high energy 
requirement and rely on oxidative catabolism, is particularly susceptible to hypoxic 
damage (Heyman et al. 2012). Oxidative catabolism is an oxygen dependent 
process by which energy substrates such as glucose are broken down to produce 
energy which is stored by cells in the form of adenosine triphosphate (ATP). 
 During ischaemia, ATP is depleted leading to increased free intracellular calcium 
concentrations that activate proteases and phospholipases leading to cell 
cytoskeleton damage and cell necrosis (Devarajan 2006; Ross 2011; Sharfuddin & 
Molitoris 2011).  Adenosine triphosphate is also metabolised further into adenine 
nucleotides and hypoxanthine. Reactive oxygen species including hydrogen 
peroxide and superoxide are then generated during the conversion of hypoxanthine 
into xanthine during reperfusion (Devarajan 2006). Ischaemia also induces nitric 
oxide generation (Devarajan 2006). These reactive oxygen species may cause 
further cell damage via oxidation, peroxidation of lipids, DNA damage and 
apoptosis (Devarajan 2006). These reactive oxygen species also contribute to the 
development of a pro-inflammatory state and may contribute to ongoing 
vasoconstriction (Cowgill & Francey 2005; Sharfuddin & Molitoris 2011). 
Ischaemia also leads to alterations in the proteins of the basolateral membrane of 
renal tubular cells, such as Na, K - ATPase and integrins (Cowgill & Francey 2005; 
Devarajan 2006; Bonventre & Yang 2011). Loss of Na, K - ATPase results in 
impaired sodium reabsorption by the proximal tubule and altered cell polarity 
(Devarajan 2006). An increased fraction of sodium reaching the macula densa 
activates tubuloglomerular feedback resulting in afferent arteriole constriction and 
reduced GFR (Ross 2011). β-integrins play an important role in tubule epithelial 
cell integrity with their relocation from the basolateral to the apical membrane 
during AKI leading to detachment of tubular cells from the basement membrane 
(Devarajan 2006). This results in denuded areas of tubule that are unable to 
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perform their metabolic functions, and also tubular obstruction by the detached 
cells. 
Disruption and redistribution of actin and actin depolymerising factor subsequent 
to cellular ATP depletion further contributes to tubular epithelial injury (Devarajan 
2006). Combined with the effects of altered membrane proteins, these changes 
cause cellular swelling, loss of microvilli, vesicle formation, necrosis and apoptosis 
that can eventually lead to cast formation and obstruction of renal tubules (Cowgill 
& Francey 2005; Devarajan 2006; Sharfuddin & Molitoris 2011).  Depletion of 
ATP also causes disruption of cell-to-cell interactions via loss of tight and adherent 
junctions resulting in back leakage of tubular filtrate, flattened epithelial cells and 
further cell detachment from the basement membrane (Ross 2011; Sharfuddin & 
Molitoris 2011). 
HAEMODYNAMIC ALTERATIONS 
During normal physiological conditions, the renal cortex receives the majority of 
renal blood flow, while the medulla receives only approximately 10% (Munshi et 
al. 2011). Ischaemia causes a regional rather than uniform pattern of reduced 
perfusion, with a disproportionate reduction of flow to the outer medulla further 
reducing flow to that area (Bonventre & Yang 2011; Munshi et al. 2011). Under 
normal physiological conditions, autoregulation allows the kidney to maintain 
constant blood flow (and therefore constant GFR) despite changes in perfusion 
pressure in the range of 80 – 180 mmHg (Eaton & Pooler 2009; Munshi et al. 
2011). However, following ischaemic injury, increased renal vascular resistance 
due to an intense and persistent vasoconstriction causes further reduction in renal 
blood flow (Devarajan 2006; Sharfuddin & Molitoris 2011). Vasoconstriction is 
exacerbated by endothelial cell injury that results in increased tissue levels of local 
vasoconstrictive mediators and increased sympathetic nervous system activity 
(Bonventre & Yang 2011). Vasoconstrictive mediators include endothelin-1, 
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angiotensin II, thromboxane A2, prostaglandin H2, leukotrienes and adenosine 
(Cowgill & Francey 2005; Devarajan 2006; Bonventre & Yang 2011). At the same 
time there is a reduced response to, and decreased abundance of, mediators of 
vasodilation including acetylcholine, bradykinin and nitric oxide (Cowgill & 
Francey 2005; Bonventre & Yang 2011). Endothelial cell injury also exacerbates 
the inflammatory response initiated during AKI, and increases microvasculature 
permeability (Bonventre & Yang 2011; Munshi et al. 2011; Sharfuddin & 
Molitoris 2011). 
INFLAMMATORY RESPONSE 
Inflammation and leukocyte activation are recognised as major mediators of 
ongoing cellular damage and hypoxia subsequent to ischaemic renal injury 
(Devarajan 2006; Sharfuddin & Molitoris 2011). Injured tubular epithelial cells 
release pro-inflammatory mediators (cytokines) that exacerbate the inflammatory 
cascades initiated by damaged vascular endothelium (Devarajan 2006). These 
cytokines include TNF-α, interleukin (IL)-6, IL-1β, IL-8, C-C motif chemokines 
and TGF β (Bonventre & Yang 2011; Sharfuddin & Molitoris 2011). Injured tubule 
cells also affect T lymphocyte activity via expression of Toll-like receptors, 
complement and complement receptors and co-stimulatory molecules (Bonventre 
& Yang 2011). Inflammatory cells including neutrophils and macrophages 
accumulate in the kidney following ischaemia; these cells produce cytokines and 
reactive oxygen species thus exacerbating tubule cell damage (Devarajan 2006; 
Bonventre & Yang 2011). 
ALTERED GENE EXPRESSION 
Transcriptomic studies have displayed altered expression of a large number of 
genes during renal I-R; including neutrophil gelatinase-associated lipocalin 
(NGAL) that is highly up regulated in the distal tubule and kidney injury molecule-
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1 (KIM-1) that is up regulated in the proximal tubule (Ichimura et al. 1998; Mishra 
et al. 2003; Supavekin et al. 2003). The precise roles of NGAL and KIM-1 are 
unclear; however they appear to be involved in the recovery process of AKI by 
reducing cell damage and inflammation (Bonventre & Yang 2011). Other 
protective proteins up regulated in the proximal tubule during ischaemic AKI 
include heme oxygenase and heat shock proteins (Bonventre & Yang 2011). 
TEMPORAL PHASES OF ISCHAEMIA-REPERFUSION ACUTE KIDNEY 
INJURY 
 AKI can be described as occurring in four different stages: initiation, extension, 
maintenance and recovery (Cowgill & Francey 2005; Devarajan 2006; Ross 2011; 
Mugford et al. 2013). The initiation phase occurs during and immediately after an 
ischaemic insult to the kidney when parenchymal damage is initiated and tubule 
cells suffer sub lethal damage (Cowgill & Francey 2005; Ross 2011). Intervention 
at this stage can potentially halt further progression of injury and reverse damage 
that has already occurred (Cowgill & Francey 2005). During the extension phase 
there is a continuation of ischaemia, hypoxia and inflammation; cell damage 
continues and functional change such as alterations to GFR and tubule reabsorption 
occur (Cowgill & Francey 2005; Ross 2011). Clinical signs and laboratory changes 
associated with AKI may still not be evident during the extension phase; however, 
by this stage renal damage may not be reversible (Cowgill & Francey 2005).  The 
maintenance phase is entered when a critical degree of epithelial damage has 
occurred; during this stage, AKI is detectable using clinical signs and traditional 
laboratory tests. Removal of the inciting cause and instigation of treatment at this 
point will not alter existing damage or increase speed of recovery (Cowgill & 
Francey 2005; Mugford et al. 2013). The final stage is the recovery phase where 
renal tissue is repaired and normal function restored over a period of weeks to 
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months. In many cases, complete recovery does not occur and scar formation and 
long-term renal dysfunction persists (Cowgill & Francey 2005). 
As renal injury is only reversible during the early stages of AKI, there is a need for 
better methods to diagnose AKI earlier so inciting causes can be removed and 
appropriate treatment instigated earlier. The next section outlines the tests that are 
available and their inherent limitations. 
CURRENT METHODS FOR DIAGNOSIS OF CANINE ACUTE KIDNEY 
INJURY 
Conventional tests for diagnosis of acute renal failure can be divided into those that 
measure GFR (sCr, creatinine clearance, blood urea nitrogen (BUN) 
concentration), those that assess renal tubular function (urine output (UOP), 
urinalysis, urine microscopy and fractional excretion of electrolytes) and those 
indicating renal tubular injury (enzyme excretion, histopathology). These tests are 
used alongside assessment of clinical signs such as sudden onset lethargy, 
depression, dehydration, anorexia, vomiting and weakness (note that these signs 
may be difficult to detect in animals already hospitalised for other critical illnesses) 
(Cowgill & Francey 2005). 
MEASURES OF GLOMERULAR FILTRATION RATE 
The gold standard method to measure GFR involves calculation of the rate of 
clearance of a substance from the plasma which is eliminated from the body only 
by glomerular filtration without any tubular reabsorption or secretion (e.g. inulin, 
iohexol and radiolabelled molecules). Unfortunately these methods can be 
complicated and expensive precluding their use in clinical veterinary practice. 
Instead, exogenous substances that are similarly freely filtered by the glomerulus 
with minimal tubular reabsorption or secretion are used as surrogate markers of 
GFR. 
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The combination of an increase in BUN concentration and sCr is referred to as 
azotaemia, and reflects a reduction in the rate of filtration of these substances by 
the glomerulus. Blood urea nitrogen is a by-product of protein metabolism. 
Unfortunately BUN concentration is a poor surrogate for GFR as although it is 
largely filtered by the glomerulus, there is also variable tubular reabsorption of 
BUN.  It is also a non-specific marker of GFR as serum levels depend on several 
extra-renal factors including nutrition and hydration status, gastrointestinal 
bleeding, liver function and steroid administration (Cowgill & Francey 2005; 
Venkataraman & Kellum 2007; Moore 2010; Cowgill & Langston 2011).  
Serum creatinine results from the breakdown of creatine and creatine phosphate by 
skeletal muscle and the liver (Braun et al. 2003).  It is a more reliable surrogate for 
GFR because it is freely filtered by the glomerulus and not reabsorbed.  However, a 
small amount does undergo tubular secretion which may account for 10-40% of 
creatinine clearance during reductions in GFR (Moore 2010). Unfortunately sCr 
can also be influenced by extra-renal factors such as muscle mass, hydration status, 
nutrition status, exercise, liver function and drugs (Moore 2010; Moore et al. 
2012). The administration of large volumes of intravenous fluids, as occurs in the 
anaesthesia and intensive care setting, may artificially lower sCr (Moore et al. 
2012).  
There are major limitations associated with the use of sCr for the diagnosis of AKI.  
It can take up to 24 hours for a detectable increase in sCr to occur following renal 
injury (Moore et al. 2012). This means that 65-75% of renal functional mass may 
have been lost before sCr increases above the reference interval (Delanghe & 
Speeckaert 2011).  As a result, AKI may not be detected until extensive injury has 
occurred, and at a time that is too late to allow useful therapeutic intervention. A 
further limitation relates to analytical error associated with the measurement of 
creatinine concentrations. Most laboratories utilise Jaffe’s method to quantify sCr, 
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and the accuracy of this method can be reduced by the presence of several 
substances within the sample, including cephalosporin or bilirubin.  As a result this 
method may overestimate sCr by up to 45% in healthy dogs (Braun et al. 2003; 
Delanghe & Speeckaert 2011). 
MEASURES OF RENAL TUBULAR FUNCTION 
Urine output monitoring 
A reduction in UOP, defined as either oliguria (< 1 mL kg
-1 
hour
-1
) or anuria (no 
urine production), has good positive predictive value for diagnosing AKI (Cowgill 
& Francey 2005; Venkataraman & Kellum 2007). However, due to the propensity 
for therapeutic interventions (fluid therapy, diuretics, dopamine) to artificially 
elevate UOP, it has poor negative predictive value and sensitivity (Venkataraman 
& Kellum 2007). Normal UOP was found in six of 29 dogs diagnosed with AKI in 
one study, and in 11 of 99 dogs diagnosed with acute renal failure in another 
(Behrend et al. 1996; Vaden et al. 1997). Another limitation of UOP monitoring is 
the requirement for indwelling urinary catheter placement. These are not routinely 
placed in veterinary patients and carry a risk of complications such as infection 
(Thoen & Kerl 2011).  
Urine specific gravity 
The measurement of urine specific gravity has conventionally been thought to be 
an important diagnostic test for AKI in small animal patients.  The production of 
isosthenuric urine (specific gravity of 1.008-1.018) is thought to reflect reduced 
concentrating ability of the renal tubules (Cowgill & Francey 2005). Interestingly, 
the use of urine specific gravity to diagnose AKI is not emphasised in human 
medicine, likely because it is heavily affected by oral fluid intake and treatments 
such as intravenous fluid therapy and diuretics (Thoen & Kerl 2011). In addition, 
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numerous endogenous and exogenous substances including artificial colloids, 
glucose or protein may affect refractometric measurements of specific gravity. 
Urinalysis and microscopy 
Further analysis of urine for abnormalities such as glycosuria and proteinuria may 
be performed; however, these are nonspecific findings in AKI because they can 
also result from extra-renal disease. Urine microscopy can demonstrate the 
presence of granular and hyaline casts formed during tubule cell damage. Despite 
good positive predictive value the presence of casts has poor sensitivity as 
demonstrated in a retrospective study where only 28 of 99 dogs with acute renal 
failure had microscopic evidence of urine casts (Vaden et al. 1997). A further 
limitation of urine microscopy is that casts are readily affected by urine storage – 
both within the body (i.e. urinary bladder) and between collection and analysis 
(Cowgill & Francey 2005). 
Fractional Excretion of Electrolytes 
Tests to calculate the fractional excretion of electrolytes are used with the premise 
that alterations to renal tubular function will result in abnormal handling of certain 
electrolytes (e.g. sodium). Unfortunately the clinical utility of these tests in 
veterinary patients is limited due to considerable intra- and inter- individual 
variation, lack of agreed reference intervals and dependency of results on dietary 
electrolyte intake (Heiene & Lefebvre 2007). 
MEASURES OF RENAL TUBULAR INJURY 
Urinary enzyme excretion 
Renal tubular cell injury results in leakage and increased urinary excretion of 
enzymes (Goldstein 2011).  Increased serum activity of these enzymes has little 
impact on urine activity because they are too large to be filtered by the glomerulus 
(Clemo 1998). Enzymes are present in the highest concentrations in the most 
 27 
 
 
 
metabolically active part of the renal tubule (i.e. the proximal convoluted tubule), 
and as mentioned earlier it is this portion that is most susceptible to ischaemic 
damage (Brunker et al. 2009). Two of the most commonly studied enzymes are Ƴ-
glutamyl transpeptidase, found in the brush border of the proximal tubule, and N-
acetyl-β-D-glucosaminidase (NAG), found in the lysosomes of the proximal tubule 
(Ward 1975; Brunker et al. 2009; Goldstein 2011). Several studies have found 
increased urinary activities of these enzymes to be more sensitive markers of acute 
tubular injury than GFR, azotaemia or clinical signs (Goldstein 2011). However 
baseline values for the urine activities of these enzymes varies greatly making it 
difficult to determine a canine reference interval, and studies have shown marked 
overlap in urine Ƴ-glutamyl transpeptidase activities between dogs with and 
without AKI (Heiene et al. 1991; Goldstein 2011). This limits the diagnostic utility 
of these tests to dogs in which baseline values have already been determined. There 
is also a wide circadian variation for urine activities of some of these enzymes; 
limiting the value of testing a single spot urine sample (Heiene et al. 1991). 
Increased urinary activity of enzymes may only be seen for a limited period 
following renal tubular damage as excretion varies with type and severity of renal 
damage (Clemo 1998). In summary, measurement of urinary enzyme activity at a 
single time point appears to be of limited diagnostic value for AKI. 
Histopathology 
Following percutaneous or laparoscopic biopsy techniques, histopathological 
examination of kidney tissue may be performed (Cowgill & Langston 2011). The 
goal of renal biopsy in a suspected case of AKI is to clarify the underlying 
aetiopathogenesis, as well as to assess severity and prognosis (Lees & Bahr 2011). 
Alterations to renal tubule histology that occur during I-R AKI have been well 
documented by various studies investigating renal I-R injury through experimental 
rodent models (Jablonski et al. 1983; Williams et al. 1997; Moosavi et al. 2009; 
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Tirapelli et al. 2009). The abnormalities appreciated during histological 
examination of tubules exposed to I-R reflect the pathophysiology of this type of 
injury as already discussed. The main tubular epithelial cell changes include: 
vacuolisation, pigmentation, pyknosis, necrosis, apoptosis and thinning or loss of 
the brush border (Williams et al. 1997; Devarajan 2006; Moosavi et al. 2009; 
Tirapelli et al. 2009). Damaged epithelial cells may detach from the basement 
membrane; this is visible as denuded areas of basement membrane and as 
exfoliated cells present within the tubular lumen (Tirapelli et al. 2009). Exfoliated 
cells may then combine with mucoproteins to become granular or cellular casts 
evident in the tubular lumen. Most of these changes can be discerned by 
examination of haematoxylin-eosin-stained sections of renal tissue using light 
microscopy. However different methods including special stains and electron 
microscopy may allow further characterisation of renal I-R injury. Many 
experimental studies formulate histopathology scoring systems to grade the 
severity of tubular damage based on some or all of the expected abnormalities 
(Jablonski et al. 1983; Moosavi et al. 2009; Tirapelli et al. 2009).  In veterinary 
medicine, renal biopsy is rarely performed, likely due to financial constraints, 
unfamiliarity with techniques in obtaining and interpreting the biopsy, and 
concerns relating to the potential for exacerbation of renal injury during biopsy 
collection (e.g. anaesthesia-induced reduction in renal perfusion, or direct renal 
injury). Unfortunately renal histopathology following AKI in veterinary patients is 
more commonly performed in a post mortem setting. 
SCORING SYSTEMS 
Diagnosis of AKI in human patients is based on scoring systems such as RIFLE 
(Risk, Injury, Failure, Loss, End-stage) and AKIN (Acute Kidney Injury Network). 
These systems use changes in sCr and UOP to detect AKI and assign a severity 
grade (Mishra et al. 2003). While conventional diagnosis of AKI in veterinary 
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patients has long involved identification of azotaemia and a low urine specific 
gravity, scoring systems similar to those used in people have recently been 
investigated (Thoen & Kerl 2011; Lee et al. 2011). These single-centre veterinary 
studies have generally detected an association between increasing severity score 
and survival time; however these scores are designed to predict severity and 
outcome rather than to detect AKI as early as possible.  The tests used in the 
scoring systems (sCr +/- UOP) have inherent limitations, as already discussed. 
These studies do help to illustrate that trends of values such as sCr are of more use 
that absolute values. The Veterinary Acute Kidney Injury staging system (Thoen & 
Kerl 2011) classifies dogs as having stage 1 AKI if sCr is increased by >150%, or 
by at least 26.5 µmol L
-1
, from baseline. Only 21% of dogs classified to stage 1 in 
that study had a sCr above the laboratory reference interval; in other words an 
increase from baseline rather than absolute value of sCr allowed for diagnosis of 
AKI in these dogs. A problem with relying on trends in these parameters to 
diagnose AKI in veterinary patients is that we very rarely have access to blood 
samples collected prior to injury (Ross 2011). 
The International Renal Interest Society (IRIS) has recently proposed an AKI 
staging system (Table 1.1). Patients are initially assigned to grade 1 - 6 depending 
on sCr, and then further sub-graded according to UOP and the requirement for 
renal replacement therapy. Grade 1 represents patients with sCr within the normal 
canine reference interval, but evidence of AKI from history, clinical findings, other 
laboratory findings or imaging. The aim of the IRIS system is to improve early 
recognition, treatment stratification and prediction of outcome in veterinary 
patients with AKI. 
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AKI grade Blood 
creatinine 
concentration 
Clinical description Subgrade 
Grade I < 140 μmol L
-1 
Non Azotaemic AKI: 
   a. Documented AKI: (Historical, 
clinical, laboratory, or imaging 
evidence of acute kidney injury, 
clinical oliguria/anuria, volume 
responsiveness), and/or 
   b. Progressive non azotaemic 
increase in blood 
creatinine; ≥0.3 mg dL-1 (≥26.4 
μmol L-1) within 48 hours 
   c. Measured oliguria (<1 mL kg
-1
 
hour
-1
) or anuria over 6 hours 
Each grade of 
AKI is further 
sub graded as: 
1. Non oliguric  
or oligoanuric 
2. Requiring 
renal 
replacement 
therapy 
Grade II 141 – 220  
μmol L-1 
Mild AKI: 
   a. Documented AKI and static or 
progressive azotaemia 
   b. Progressive azotaemic increase 
in blood creatinine; ≥0.3 mg dL-1 
≥26.4 μmol L-1) within 48 hours), 
or volume responsiveness‡ 
   c. Measured oliguria (<1 mL kg
-1
 
hour
-1
) or anuria over 6 hours 
 
Grade III 221 – 439  
μmol L-1 
  
Grade IV 440 – 880 
 μmol L-1 
Moderate to Severe AKI: 
   a. Documented AKI and 
increasing severities of azotaemia 
and functional renal failure 
 
Grade V > 880 μmol L
-1 
  
 
Table 1.1 Summary of the International Renal Interest Society’s 2013 “Grading of 
acute kidney injury” (Cowgill & Langston 2011). 
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THE FUTURE FOR ACUTE KIDNEY INJURY DIAGNOSIS 
Given the pathophysiology of AKI, it is evident that the window of intervention to 
prevent ongoing damage following an ischaemic insult is short and occurs early in 
the syndrome. In order to detect patients in this early phase, a reliable diagnostic 
test is required. However, as discussed, it is clear that no such test exists.  
It has been suggested that the ideal test would be non-invasive, rapid and easy to 
perform and robust, as well as sensitive and specific for the diagnosis of AKI 
(Devarajan 2010a). The search for the ideal marker has been a busy area of 
research in the human medical field for the last decade, with transcriptomic studies 
shifting interest towards novel biomarkers of renal structural damage, such as urine 
and serum concentrations of NGAL and KIM-1 (Moore et al. 2012). Veterinary 
interest has been slow to develop with only a handful of published studies 
investigating the use of these biomarkers in small animal species. The summary of 
a recent study into a staging system for canine AKI highlighted the importance of 
veterinary investigation into biomarkers such as NGAL concentration (Thoen & 
Kerl 2011).  The following section will summarise current knowledge regarding 
this biomarker. 
NEUTROPHIL GELATINASE-ASSOCIATED 
LIPOCALIN 
STRUCTURE, ORIGIN AND FUNCTION 
Neutrophil gelatinase-associated lipocalin is a 45-kDa member of a family of 
small, secreted glycoproteins known as lipocalins, first identified in human 
granulocytes during a search for a marker of neutrophils (Flower 1996; Xu & 
Venge 2000). Lipocalins are a diverse family of proteins with a wide range of 
structures and functions, and common to all lipocalins are molecular recognition 
abilities such as binding to hydrophobic ligands, binding to cell-surface receptors 
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and formation of macromolecular complexes (Flower 1996). Lipocalins share a 
common ‘folding pattern’ consisting of a cup-shaped pouch inside a barrel of β 
protein sheets closed at each end with α helices (Fig. 1.2) (Flower 1996; 
Chakraborty et al. 2011). The fold’s purpose is ligand binding, with different 
lipocalins having different binding selectivity (Flower 1996).  
 
Figure 1.2 The structure of the NGAL: the “lipocalin fold” comprises of 
eight β sheets (A-H) with the eighth connected to an α helix (α1). Diagram 
from Chakraborty et al. 2011. 
NGAL expression has been identified in various cells and tissues including 
neutrophils, macrophages, lung, trachea, stomach, intestine, kidney, liver, bone 
marrow, thymus, prostate, uterus and adipose tissue (Flower 1996; Xu & Venge 
2000; Chakraborty et al. 2011). Studies using ‘reporter mice’ have revealed that the 
origin of NGAL produced by the kidney is the epithelia of the thick ascending limb 
of Henle and collecting ducts; most of this renal NGAL is excreted in the urine 
(Haase et al. 2011b; Paragas et al. 2011). In the absence of AKI, the expression of 
NGAL by the distal nephron is small, however expression increases during tubular 
injury (Fig. 1.3) (Schmidt-Ott 2011). NGAL in the plasma may consist of some 
NGAL from non-renal origins (i.e. neutrophils and other organs), this NGAL is 
filtered by the glomerulus and then reabsorbed by the proximal tubules (thus only 
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entering the urine if there is failure of reabsorption) (Mori et al. 2005; Schmidt-Ott 
et al. 2007). It is known that different molecular forms of NGAL exist: the 
monodimer being of renal origin, and the homodimer form of neutrophil origin 
(Bangert et al. 2012; Lippi & Cervellin 2012). 
 
Figure 1.3 Renal transport of NGAL in (a) the normal kidney and (b) 
during AKI. (Diagram modified from Schmidt-Ott 2011). 
Multiple roles have been suggested for NGAL with bacteriostatic abilities one of 
the most important. Neutrophil gelatinase-associated lipocalin has been shown to 
bind with strong affinity to siderophores (bacterial iron binding sites) thus 
depriving bacteria of an essential nutrient (Goetz et al. 2002; Yang et al. 2002; 
Mori et al. 2005; Chakraborty et al. 2011). Other suggested functions of NGAL 
include chemoattraction of neutrophils, inhibition of cellular oxidative stress, 
proliferation and synthesis of cartilage and proliferation of renal tubular epithelial 
cells (Chakraborty et al. 2011). It has been shown that introduction of systemic 
NGAL to mice prior to ischaemic kidney injury leads to improvement in 
subsequent kidney function with enhanced expression of protective enzymes, 
blunting of cell death and fewer abnormalities on renal histopathology when 
compared to mice that did not receive systemic NGAL (Mishra et al. 2004; Mori et 
al. 2005). 
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IDENTIFICATION OF THE INVOLVEMENT OF NEUTROPHIL 
GELATINASE-ASSOCIATED LIPOCALIN IN KIDNEY INJURY 
 
Neutrophil gelatinase-associated lipocalin has been identified as one of the most up 
regulated genes during renal I-R injury in a rodent model (Supavekin et al. 2003). 
Further investigations provide additional evidence of consistent up-regulation of 
NGAL within three hours of I-R injury, particularly in the proximal tubules 
(Supavekin et al. 2003). One study also assessed urine NGAL concentration 
(uNGAL) in mice and rats following renal ischaemia and found it to be easily 
detected in urine at the first sampling time of two hours after ischaemia.  
Furthermore, the appearance of increased uNGAL was associated with severity and 
duration of ischaemia (Mishra et al. 2003). These early rodent studies led to a 
plethora of human clinical trials to assess the usefulness of uNGAL as biomarker 
for the early diagnosis of AKI.  
HUMAN CLINICAL STUDIES 
A comparison between sCr and uNGAL or serum NGAL concentration (sNGAL) 
for the diagnosis of AKI following paediatric cardiopulmonary bypass was the first 
clinical study to be published (Mishra et al. 2005). A significant correlation was 
present between AKI (defined as a ≥ 50% increase in sCr from baseline) and 
increased uNGAL or sNGAL two hours post bypass. It should be noted that two 
hours was the first sampling time; therefore changes in NGAL concentration could 
have occurred earlier. Other similar studies have evaluated the use of uNGAL 
and/or sNGAL measurement in both adults and children in various settings, mainly 
during cardiopulmonary bypass or in the intensive care unit. An association 
between increased NGAL concentration measured as early as one hour post renal 
injury and the development of AKI has been found, with a relationship detected 
between NGAL concentration and severity and duration of AKI, length of hospital 
stay, requirement for renal replacement therapy and death in many studies (Dent et 
 35 
 
 
 
al. 2007; Bennett et al. 2008; Nickolas et al. 2008; Haase et al. 2009; Devarajan 
2010b; Macdonald et al. 2012). Unfortunately, many of these clinical studies have 
inherent limitations including being small, single-centre trials and the use of SCr 
for the definitive diagnosis of AKI rather than the gold standard, renal biopsy. 
It should be stressed that unlike sCr, changes in NGAL concentration reflect renal 
tubular damage rather than changes in GFR. The difference between the role of sCr 
and uNGAL in AKI diagnosis has been described using a ‘forest fire’ analogy; 
where sCr is a measure of functional nephrons (‘trees’), and uNGAL the real-time 
extent of tubular lesions (the ‘fire) (Mori & Nakao 2007). As change in uNGAL 
represents structural change to the kidney, it would not be expected to increase in 
purely pre-renal azotaemia (Schmidt-Ott 2011). Indeed, several clinical studies in 
human patients have confirmed an absence of a significant increase in uNGAL in 
patients with pre-renal azotaemia compared to those with intrinsic renal injury 
(Nickolas et al. 2008; Singer et al. 2011). These differences make uNGAL an 
earlier and more specific marker for acute tubular injury in comparison to sCr; and 
explain the apparent ability of uNGAL to predict severity of disease. In a recent 
meta-analysis of 2322 critically ill humans; 4.6% of patients with an increased 
NGAL concentration did not have a subsequent increase in sCr, with 2.5% of those 
patients going on to require renal replacement therapy (Haase et al. 2011a). This 
highlights that NGAL concentration may be better able to predict patients in the 
very early stages of AKI that may benefit from instigation of treatment at that time. 
POTENTIAL LIMITATIONS OF NEUTROPHIL GELATINASE-
ASSOCIATED LIPOCALIN CONCENTRATION IN ACUTE KIDNEY 
INJURY DIAGNOSIS 
 
A limitation to the diagnostic value of uNGAL is the potential for changes in urine 
concentration and flow to alter uNGAL. To avoid this bias it has been suggested 
that correction for differences in urine concentration be performed when reporting 
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the concentration of urinary biomarkers. Normalisation of biomarker concentration 
to urine creatinine concentration may be used and involves measurement of urinary 
creatinine concentration and subsequent calculation of the uNGAL: urinary 
creatinine concentration (UNCR) (Goldstein 2010; Grenier et al. 2010). However, 
in order for urine creatinine concentration to be used for normalisation it is 
assumed that its excretion rate is constant both within an individual over time, and 
between individuals (Waikar et al. 2010; De Loor et al. 2013). During the early 
stages of AKI the GFR is likely to be changing rapidly leading to unstable urinary 
excretion of creatinine; in addition back-leak of creatinine across injured tubules 
may occur (Waikar et al. 2010). These changes are likely to result in an increased 
biomarker: creatinine ratio immediately after a reduction in GFR regardless of 
whether production of the biomarker itself is increased or not (Waikar et al. 2010; 
Ralib et al. 2012). A recent study comparing different methods of reporting urinary 
NGAL excretion in humans found that uNGAL performs best in AKI diagnosis, 
whereas UNCR is a better predictor of severity of disease (Ralib et al. 2012). 
Subsequently, it was suggested that uNGAL should be reported independently and 
as the UNCR in scientific reports investigating the use of urinary biomarkers in 
order to facilitate interpretation of results (Ralib et al. 2012). Calculation of urinary 
osmolality may also be used to correct for differences in urine concentration, 
however may be subject to similar limitations as UNCR during periods of low GFR 
(Tomonaga et al. 2012). 
Concern has been raised as to the origin of the NGAL identified in urine and serum 
following renal injury, given that NGAL is not an organ-specific marker (Smertka 
& Chudek 2012). Elevated sNGAL has been noted in patients with lower 
respiratory tract infections, systemic inflammatory disease, thrombocytopenia, 
polycythaemia and neoplasia, while urinary tract infections may lead to elevated 
uNGAL (Smertka & Chudek 2012). Of particular concern has been potential 
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neutrophil origin for circulating NGAL rather than direct renal origin. To address 
this concern it has been postulated that uNGAL rather than sNGAL may correlate 
better with AKI. The NGAL excreted in the urine is believed to be of distal tubular 
origin (Fig. 1.3). In addition, the development and use of assays that are able to 
distinguish between the monodimer and homodimer forms of NGAL can allow 
resolution of this problem (Bangert et al. 2012).  
Effects of pyuria and urinary tract infection (UTI) on uNGAL have recently been 
investigated in a canine study (Daure et al. 2013). Urinary NGAL concentration 
was measured in 80 dogs with UTI, and 19 healthy dogs with no evidence of UTI. 
Both uNGAL and UNCR were higher in dogs with UTI, however, only uNGAL 
varied significantly with the presence of pyuria. The authors were unable to 
determine whether the increased uNGAL was due to pyuria alone or to the disease 
process of a UTI. The assay used in the study did not differentiate between difficult 
molecular forms of NGAL. 
A further concern regarding the use of NGAL as a diagnostic marker for AKI in 
humans is the wide variability in NGAL concentrations in patients without AKI 
(Smertka & Chudek 2012). This has made development of a reference interval 
difficult, and it has been shown that cut-off values for NGAL concentration to 
detect AKI are specific to each different patient population (Smertka & Chudek 
2012). 
NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN IN 
VETERINARY LITERATURE 
Despite the availability of a canine specific NGAL enzyme-linked immunosorbent 
assay (ELISA), to date there are few veterinary papers published on the use of 
NGAL concentration as a diagnostic marker of renal disease. However, all 
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published canine clinical studies report a significantly increased uNGAL or UNCR 
in patients with AKI compared to patients without AKI. 
The first published clinical study investigated changes in uNGAL following 
anaesthesia and surgery (Lee et al. 2012). Urine and serum samples were collected 
pre- and post-surgery from 39 dogs undergoing routine orthopaedic and soft tissue 
surgical procedures. Samples were collected every 12-24 hours from 12 hours post-
surgery; however a sample was not collected from every dog at every time interval. 
Absolute NGAL concentration (rather than UNCR) was reported. Twelve of these 
dogs developed AKI as diagnosed by an increase in sCr of ≥ 26.5 μmol/L from 
baseline within 48 hours. The authors found that uNGAL at 12 hours post-surgery 
increased approximately 3.5 times from baseline in the dogs that were subsequently 
diagnosed with AKI, while there was no such change in uNGAL in the dogs that 
did not develop AKI. Interestingly sNGAL did not change in the dogs that 
developed AKI.  Unfortunately, this study was limited in that it involved sample 
collection from only a small number of dogs, and there was no standardisation in 
surgical procedure, anaesthetic protocol or post-operative care. Due to the first 
sample time point being 12 hours post-surgery, the study was not designed to 
detect an early increase in NGAL concentration similar to that seen in human 
patients. 
A small number of clinical canine studies have examined the use of NGAL 
concentration to diagnose AKI and CKD. One prospective study involved the 
collection of urine samples from 28 healthy dogs, 17 dogs with lower urinary tract 
disease, 20 dogs with CKD, 21 dogs with azotaemic AKI (IRIS stages 2-4) and 8 
dogs with non-azotaemic AKI (IRIS stage 1) (Segev et al. 2013).  Of the non-
azotaemic dogs, seven developed AKI subsequent to heatstroke, and one developed 
AKI following general anaesthesia. Statistical analysis identified that UNCR values 
of the AKI groups were the highest of all groups, but there was no significant 
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difference between UNCR in dogs with azotaemic and non-azotaemic AKI. There 
was no correlation between UNCR and sCr. Receiver operating characteristics 
analysis of UNCR as a marker of azotaemic or non-azotaemic (IRIS Grade 1) AKI, 
when compared to non-AKI renal and urinary conditions, had an area under the 
curve of 0.94 and 0.96 respectively. Unfortunately, this study was limited by the 
inclusion of only a small number of dogs with AKI, particularly in the non-
azotaemic group. 
A single-centre clinical study investigated uNGAL and sNGAL in 17 dogs with 
AKI, 40 dogs with CKD and 12 healthy dogs (Hsu et al. 2014). Diagnosis of AKI 
was made on the basis of azotaemia being present for less than seven days and the 
absence of other clinical signs of CKD. Renal histopathology was not performed. 
Azotaemic dogs had increased sNGAL and uNGAL compared to control dogs. 
There was no association of sNGAL or uNGAL with 30 day mortality rate in dogs 
with AKI. However, sNGAL was found to be a better prognostic indicator for 
CKD survival than sCr. This study was again limited by a small sample size. There 
was large variation in the timing of sample collection in the disease process, and 
urine and serum samples were not always collected at the same time. Absolute 
NGAL concentrations rather than UNCR were reported. Without the use of 
histopathology, the method chosen to divide patients into AKI or CKD groups 
(duration of azotaemia and clinical history) may also have led to some patients 
with acute disease being classified as having CKD. 
Another clinical study involved collection of urine and plasma samples from 18 
healthy dogs, 17 dogs with CKD and 48 dogs with AKI (Steinbach et al. 2014). 
The underlying causes of AKI were not disclosed. The samples were collected 
once for each patient, during the first 24 hours of presentation to the clinic or 
within 24 hours of development of AKI. Acute kidney injury was diagnosed on the 
basis of presence of renal azotaemia that persisted for at least 24 hours with a USG 
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< 1.025. If azotaemia resolved within 24 hours of fluid therapy it was assumed to 
be pre-renal and these dogs were excluded from the study. Urine NGAL 
concentration and plasma NGAL concentration, as well as UNCR, were higher in 
dogs diagnosed with AKI compared to healthy dogs. Plasma NGAL concentration, 
but not uNGAL was also higher in dogs with AKI when compared to those with 
CKD. Although this study investigated a larger cohort of dogs compared to 
previous studies, unfortunately 31 of the 48 dogs diagnosed with AKI were anuric, 
meaning that data for uNGAL and UNCR was only available for 17 dogs with 
AKI. Also, the exclusion of patients with ‘pre-renal’ azotaemia may have excluded 
some dogs with AKI given the previously discussed failings of sCr and urine 
specific gravity to accurately reflect tubular injury. 
Finally, more recent studies have evaluated the value of NGAL measurement for 
the diagnosis of CKD in dogs. The use of various urinary biomarkers to diagnose 
and stage CKD in dogs with X-linked hereditary nephropathy was investigated in 
25 related male mixed breed colony dogs that tested positive for the genetic 
mutation (Nabity et al. 2012). Urine NGAL concentration increased early in the 
disease process, however in the mid and later stages of CKD there was no further 
change; suggesting that uNGAL may be less useful to stage more advanced cases 
of CKD.  
Serum NGAL concentration has been compared in 62 dogs diagnosed with CKD 
and eight normal dogs (Ahn & Hyun 2013). In dogs with IRIS stages 3 and 4 
(moderate and severe) CKD, sNGAL was higher than in control dogs, and strongly 
correlated to sCr and BUN concentrations. However, sNGAL did not correlate well 
with severity of disease despite being significantly higher in dogs with IRIS stage 4 
CKD. This inability to detect any correlation may have been due to the wide range 
of sNGAL concentrations in dogs with this late stage of CKD. The authors suggest 
that sNGAL’s prognostic performance was poor in the later stage of CKD in their 
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study because sNGAL only increases as a result of active injury, rather than due to 
changes in renal function (which are the parameters used to stage CKD). 
 
SUMMARY 
Acute kidney injury is an important disease in canine patients with a high mortality 
rate. Given the self-perpetuating nature of the renal injury prevention and early 
identification are essential. NGAL has been highlighted as a valuable diagnostic 
tool for AKI in human patients, and as such further investigation into its use in the 
veterinary field is warranted. As well as potential as a clinical diagnostic tool, with 
further validation canine NGAL may become useful as a research method to 
diagnose and potentially stage the development of AKI during studies into the 
pathophysiology, treatment and prevention of AKI during general anaesthesia and 
critical illness in veterinary patients. Despite the recent publication of clinical 
veterinary studies examining the use of NGAL concentration to diagnose AKI and 
chronic renal disease, no one has described early changes in uNGAL in veterinary 
species using a clinically relevant model. Only one study has investigated the 
magnitude of change from baseline in individual dogs at specific time periods 
during AKI (Lee et al. 2012). Furthermore, all canine studies investigating uNGAL 
to date have relied upon the finding of an increased sCr without clinical signs 
consistent with chronic renal disease to diagnose AKI; definitive diagnosis using 
renal biopsy has not been performed.  
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STUDY AIM AND HYPOTHESIS 
The objective of this study was to describe the very early changes in uNGAL in 
dogs subjected to AKI induced by a model of I-R. 
The first aim of the study was to develop a canine I-R model that would produce 
histological evidence of renal tubular damage. It was hypothesised that ischaemia 
induced by hypotension for more than 30 minutes, and reperfusion achieved by 
fluid resuscitation for more than 60 minutes, would be required to produce such 
damage. 
The second aim was to optimise the use of a commercial dog NGAL ELISA for 
use in our laboratory. It was hypothesised that dilution of urine samples required in 
order to measure NGAL within the dynamic range of the assay would be higher 
than manufacturer’s recommendations. 
The third aim was to use the model to determine the early temporal pattern of 
change in uNGAL following I-R. It was hypothesised that uNGAL would increase 
significantly from baseline within three hours following I-R due to acute 
haemorrhage and fluid resuscitation. 
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CHAPTER 2 – ESTABLISHMENT OF A 
MODEL FOR THE ASSESSMENT OF 
BIOMARKERS OF ACUTE KIDNEY INJURY 
 
INTRODUCTION 
There has been recently been interest in the use of novel biomarkers for early 
diagnosis of AKI in dogs, due to limitations of current diagnostic methods. Of 
these, NGAL has received a lot of attention in the veterinary and medical literature. 
Several large and multi-centre clinical studies in humans have shown that uNGAL  
and sNGAL increase from as early as two hours following the initiation of I-R 
kidney injury subsequent to various aetiological factors (i.e. cardiopulmonary 
bypass, sepsis) (Smertka & Chudek 2012). A few small clinical studies 
investigating the use of uNGAL to diagnose I-R AKI in dogs have been reported. 
While these canine studies show elevated uNGAL in dogs from 12 hours of AKI 
initiation, no studies have so far investigated usefulness of the biomarker in the 
very early stage of the syndrome (Lee et al. 2012). The previous clinical veterinary 
studies were also limited by their small sample size and lack of standardisation 
including the method for confirming AKI and the stage of disease at which 
uNGAL was measured. 
To date, most experimental investigations of novel biomarkers (such as NGAL) 
have used complete occlusion to flow by clamping renal vasculature for varying 
time periods to create I-R in rodent models (Mishra et al. 2003; Supavekin et al. 
2003; Mishra et al. 2004; Mori et al. 2005). Whilst these models have been useful 
for identification of early biomarkers of AKI, they lack clinical relevance as 
reduction in renal perfusion rather than complete occlusion to flow is more likely 
to occur in veterinary and human patients (Li et al. 2012; Moore et al. 2012).  
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Pressure-guided haemorrhage models have previously been used to create 
haemorrhagic shock in dogs in order to study the cardiovascular effects of 
hypovolaemic shock, and to investigate possible treatments for kidney injury 
(Sabouni et al. 1988; Chintala & Jandhyala 1990; Tsukamoto & Pape 2009).  The 
fixed pressure model, first suggested by Wiggers, involves reduction of MAP 
below a certain threshold for a set time period (Wiggers 1942). An alternative 
method is to use a set volume model, where a standardised volume is removed 
from all patients. However in the set volume model, variation in blood pressure can 
be observed due to differences in ability of patient to compensate for the volume 
deficit. Using a fixed pressure model reduces this variability, producing a more 
standardised reduction in blood pressure and thus organ perfusion. This type of 
canine model has not previously been used in research assessing AKI diagnosis; 
hence the duration and magnitude of haemorrhagic shock required to produce AKI 
is unknown. This must be determined before the model can be used to investigate 
novel biomarkers of I-R AKI. 
To develop a robust model of disease for the validation of novel biomarkers; it is 
important that injury can be confirmed, even quantified, using the most accurate 
test possible, i.e. a ‘gold standard’. Currently the gold standard for confirming the 
presence of AKI in humans and veterinary species is histopathology. Many 
previously reported animal models of AKI have used histopathology to document 
the extent of renal damage induced. Unfortunately most of these studies extend the 
reperfusion stage to several days, and consequently renal histopathology changes 
are not well documented during the very early stages of AKI. In veterinary clinical 
practice renal biopsy is rarely utilised; and generally limited to the diagnosis of 
chronic renal disease. Hence there are limited data to suggest how early 
histopathology changes can be identified during AKI, and what severity of insult is 
necessary to produce such changes. Furthermore, it may be difficult to distinguish 
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acute tubular necrosis from autolysis unless histopathologic examination is 
performed by an experienced pathologist using a strict grading criterion (Kocovski 
& Duflou 2009). 
A canine specific ELISA capable of determining NGAL concentration in urine, 
plasma or serum, tissue extracts and culture media is commercially available for 
research purposes (Dog NGAL ELISA Kit, Bioporto® Diagnostics, Denmark). The 
availability of such a test provides opportunity to explore the usefulness of this 
biomarker in canine patients. However it has been noted previously that canine 
urine samples often require dilution in order to obtain concentrations within the 
working range of the assay (Steinbach et al. 2014). Before such an assay can be 
established for use in a research laboratory, its operating procedure must be 
assessed to ensure good performance across the range of NGAL concentrations 
expected. 
The objectives of this pilot investigation were to i) determine if MAP < 40 mmHg 
for 30 or 60 minutes, followed by 1 or 2 hours of reperfusion associated with fluid 
administration, was sufficient to produce histopathological evidence of acute 
tubular damage within two hours of reperfusion; ii) determine if increases in 
uNGAL and sNGAL can be observed within two hours of reperfusion and iii) 
determine the magnitude of increase in uNGAL and sNGAL at various durations of 
I-R and thus subsequent dilutions that may be required for measurement of NGAL 
in future studies.   
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METHODS 
ANIMALS 
Six male entire greyhound dogs (range: 30.5 – 36.5 kg body weight) were used for 
this pilot study (Table 2.1). Ethics approval for the study was obtained from the 
Murdoch University Ethics Committee (permit number R2389/11) and the dogs 
were cared for according to the “Australian code for the care and use of animals for 
scientific purposes”. Dogs were included in the study if deemed to be in good 
health based on a physical examination. Food was removed at least eight hours 
prior but ad lib access to water was provided up to premedication. 
ANAESTHESIA  
Premedication was provided with intramuscular methadone (0.3 mg kg
-1
) 30 
minutes prior to induction of general anaesthesia. Access to water was removed at 
time of premedication. A 20 gauge 1.16 inch cannula was placed in the cephalic 
vein. Anaesthesia was induced with alfaxalone (Alfaxan injection 10mg mL
-1
, 
Jurox, Australia) 1.3-2.7 mg kg
-1
 by slow intravenous (IV) injection, until sufficient 
depth of anaesthesia was obtained to provide suitable conditions for orotracheal 
intubation. An orotracheal tube was placed, and the dog positioned in left lateral 
recumbency. The orotracheal tube was connected to a circle rebreathing system and 
anaesthesia was maintained using isoflurane (I.S.O., VCA, Australia) delivered in 
2 L minute
-1
 of up to 100% oxygen. The lungs were ventilated with a time-cycled 
volume control ventilator at an initial tidal volume of 20 mL kg
-1
 and respiratory 
rate of 10 breaths per minute. Tidal volume was adjusted to ensure normocapnia 
prior to the start of the study. Intravenous Hartmann’s solution (Compound Sodium 
Lactate, Baxter Healthcare Pty Ltd, Australia) was administered via the peripheral 
venous catheter at 10 mL kg
-1
 hour
-1
. Dogs were warmed with a forced warm air 
blanket (Bair Hugger warming unit Model 505, Critical Assist, Australia) placed 
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over the dog and heating mat placed under the dog. Routine anaesthetic monitoring 
was performed at five minute intervals using a multi-parameter monitor (Surgivet 
V9203; Smiths Medical, USA) and included heart rate, respiratory rate, end-tidal 
carbon dioxide, pulse oximetry, core temperature, three-lead electrocardiography 
and non-invasive blood pressure measurement.  
INSTRUMENTATION  
Instrumentation was performed within the first 30 minutes of induction and 
included cannulation of the femoral artery, and placement of a urinary catheter. 
The left femoral artery was cannulised to facilitate measurement of arterial blood 
pressure and removal of blood to generate experimental haemorrhage. Following 
regional anaesthesia of the femoral nerve with bupivacaine 0.5%, the femoral 
artery was surgically exposed and a 14 gauge 3 inch cannula inserted and secured 
in place. For measurement of arterial blood pressure, the femoral artery catheter 
was connected by fluid filled non-distensible tubing to an electronic pressure 
transducer (DTX Plus, Argon Critical Care Systems, Singapore) placed at the level 
of the right atrium and attached to the multi-parameter monitor which displayed 
and recorded the arterial pressure waveform continuously as well as systolic, 
diastolic and mean blood pressure. The transducer was zeroed to atmospheric 
pressure before use, then flushed with heparinised saline prior to each 
measurement, and opened to the atmosphere at the end of each study to confirm the 
absence of baseline drift. An 8 French 55 centimetre Foley urinary catheter was 
placed for collection of urine samples. After instrumentation, the dog was 
repositioned in dorsal recumbency and allowed to stabilise before starting baseline 
measurements.  
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ISCHAEMIA - REPERFUSION MODEL 
Following instrumentation, each dog was subjected to varying duration of I-R 
(Table 2.1). Ischaemia was generated via experimental blood loss by removing 
blood from the femoral arterial catheter. Sufficient volume was removed to 
maintain mean arterial blood pressure (MAP) below 40 mmHg. The reduced MAP 
was maintained for 30 minutes in Dog 2 and 60 minutes in the other five dogs 
(Table 2.1). Two to three standard units (32 - 48 mL kg
-1
) of blood was collected 
over the first 20-30 minutes and then increments were removed as required to 
maintain MAP < 40 mmHg. The total volume of blood removed from each dog 
was recorded. After haemorrhage, reperfusion was produced by administration of 
fluid to increase and maintain MAP > 60 mmHg. Each dog received synthetic 
colloid +/- Hartmann’s solution (Compound Sodium Lactate, Baxter Healthcare 
Pty Ltd, Australia) 40 mL kg
-1
 hour
-1
 IV to maintain MAP > 60mmHg during the 
reperfusion period (Table 1). As synthetic colloids are excreted in urine to a 
variable extent, two colloids, commonly used clinically, were chosen to screen 
for possible effects of colloid molecule on measurement of uNGAL: either 
succinylated gelatine solution 4% (Gelofusine®, B Braun Australia Pty Ltd, 
Australia) or 6% hydroxyethyl starch 130/0.4 (Voluven®, Fresenius Kabi Australia 
Pty Ltd, Australia). Duration of reperfusion was 60 or 120 minutes (Table 2.1). At 
the end of the reperfusion period the dogs were euthanised by rapid intravenous 
administration of pentobarbitone 150 mg kg
-1
(Lethabarb Euthanasia Injection, 
Virbac, Australia). 
 
DATA COLLECTION 
Collection of urine and blood samples was performed approximately 60 minutes 
after induction of anaesthesia prior to haemorrhage (T0), immediately following 
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the haemorrhage (ischaemic) phase (T1); and then every 30 - 60 minutes during 
reperfusion. Urine samples were collected for all six dogs, but blood was collected 
only in dogs 2, 4, 5 and 6. Urine was collected from the urinary catheter and stored 
on ice for up to two hours. All urine in the bladder was removed at each sample 
time. Samples were then centrifuged for 5 minutes at 250 g to remove sediment. 
Blood was collected from the jugular vein and placed in serum tubes, allowed to 
clot, and centrifuged for 10 minutes at 500 g. Aliquots of both urine and serum 
were stored at -18 to -20
o
C for up to 24 hours prior to storage at -80
o
C for later 
measurement of NGAL concentration.  
Immediately following euthanasia, both kidneys were harvested from five of the 
dogs (dogs 2 – 6) and 5 – 7 mm thickness cortico-medullary sections taken from 
the centre of each kidney were placed in 10% formalin. Samples were processed 
routinely, embedded in paraffin, sectioned at 3µm thickness and stained with 
haematoxylin and eosin and periodic acid-Schiff. One veterinary pathologist, 
unaware of the duration of I-R, examined cortex and medulla of the sections by 
light microscopy. In order to quantify tubular damage, sixty cortical fields (10X) 
from each kidney were chosen at random and then assessed for the presence of 
tubular damage. Tubular damage was defined as the presence of single cell 
necrosis / apoptosis, or the presence of epithelial cells undergoing vacuolar 
degeneration. The average number of damaged tubules per fields across both 
kidneys was calculated for each dog.  
NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN ASSAY 
 
Neutrophil gelatinase-associated lipocalin concentrations in urine and serum were 
determined using a commercially available canine NGAL ELISA (Dog NGAL 
ELISA Kit, BioPorto Diagnostics, Denmark). Initially the ELISA was performed 
using the manufacturer’s recommended sample dilution of 1 in 100 (Plate 1). All 
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samples of serum or urine collected from the six dogs were included with each 
sample measured in duplicate. A subsequent plate (Plate 2) was used to investigate 
different dilutions when results fell out with the measureable range of the assay (4 
– 400 pg mL-1). 
The assay was performed according to the manufacturer’s instruction (Dog NGAL 
ELISA Kit, BioPorto Diagnostics, Denmark). The assay is a sandwich ELISA 
performed in microwells coated with a mouse monoclonal antibody against canine 
NGAL. Bound NGAL is detected with a mouse monoclonal antibody labelled with 
biotin and the assay is developed with horseradish peroxidase—conjugated 
streptavidin and a colour forming substrate.  The limit of detection of the assay was 
0.56 pg mL
-1
, with an intra-assay coefficient of variation (CV) of 1.5% for urine 
and 2.5% for plasma. 
Seven calibrator NGAL standards of concentrations 1, 4, 10, 20, 40, 100, 200 and 
400 pg mL
-1
 were provided and used. Samples were diluted using the sample 
diluent provided, and mixed by moderate vortexing. 100µL of calibrator or diluted 
sample was added to each well, the plate was then incubated for one hour at room 
temperature on a shaking platform set at 200 revolutions per minute. The plate was 
washed with the wash buffer provided for three wash cycles using an automatic 
washer, then 100µL of biotinylated dog NGAL antibody added to each well. The 
plate was again incubated for one hour at room temperature on a shaking platform 
before three wash cycles to remove unbound detection antibody. 100µL of 
horseradish peroxidase-streptavidin was then added to each well, and the plate 
incubated for one hour at room temperature before three wash cycles were applied 
to remove unbound conjugate. Finally, 100µL of tetramethylbenzidine was added 
to each well and incubated in the dark for ten minutes before 100µL of dilute 
sulphuric acid was added to stop the colour change reaction. The optical density 
(absorbance) of each well was read at 450nm using an ELISA plate reader 
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(iMark™ Microplate Absorbance Reader, Bio-Rad Laboratories, USA). The results 
of this plate demonstrated several measurements of NGAL concentration that lay 
out with the measureable range thus analysis of a second plate was performed.  
The second NGAL ELISA plate contained serial dilutions of the four urine samples 
with the highest NGAL concentration and four urine samples with the lowest 
NGAL concentration, as measured in plate one. Urine containing a high NGAL 
concentration was diluted to 1 in 100, 1 in 200, 1 in 400, 1 in 800 and 1 in 1600. 
Urine with a low NGAL concentration was diluted to 1 in 25, 1 in 50, 1 in 75 and 1 
in 100; an undiluted sample was also included. The ELISA procedure was then 
performed exactly as described above, with all samples included in duplicate. 
CONTROL DOG 
To investigate the effects of autolysis alone on renal histology, one additional 
greyhound dog (“control dog”) underwent direct euthanasia, rather than general 
anaesthesia and haemorrhage. Following placement of a cephalic intravenous 
cannula, intravenous pentobarbitone 150 mg kg
-1
 was administered. Upon 
confirmation of death both kidneys were harvested in a method identical to that of 
the other six dogs, and stored in formalin. The same renal pathologist, blinded to 
the identity of the dog, then examined tissue sections stained with haematoxylin 
and eosin and periodic acid-Schiff from both kidneys. 
STATISTICAL ANALYSIS 
For each ELISA plate, a calibration curve was created using a trend line generated 
by an ELISA software program (MPM6 Microplate Manager Software; BioRad 
Laboratories Inc, CA, USA) using a linear y-axis (absorbance) and log x-axis 
(concentrations of standards) fitting a 4-parameter logistic curve (Fig. 2.1). The 
NGAL concentration (pg mL
-1
) could then be calculated as proportional to the 
absorbance value. Coefficient of variation was calculated for all duplicates of 
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samples within a single ELISA plate. The mean of duplicated sample 
measurements was recorded as the sample concentration, however if the coefficient 
of variance between the two results was more than 15% the result was discarded. 
For ELISA plate two; the CV was also calculated between subsequent dilutions of 
the same urine sample. Data were reported as mean (confidence interval, CI) if 
normally distributed, or median (interquartile range, IQR) if not normally 
distributed.  
RESULTS 
Target MAP was achieved in five dogs; however difficulty was experienced 
maintaining the MAP of Dog 5 below 40 mmHg for 60 minutes consistently due to 
the development of pulsus alternans with complete absence of every second pulse 
and associated increase in the pressure generated by remaining pulse (Table 2.1, 
Fig. 2.2). It is presumed that the slower mechanical activity allowed improved 
ventricular filling during diastole and thereby increased cardiac output and MAP. 
The mean (95% CI) volume of blood required to be withdrawn to achieve MAP 
<40 mmHg for the period of haemorrhage was 50.0 mL kg
-1
 (range: 43.2 – 56.8). 
Urine output was sufficient to obtain urine samples by 30-minute reperfusion in 
only three dogs (Dogs 1, 4 and 5); UOP was sufficient in the remaining three dogs 
by 60-minute reperfusion. 
Average number of damaged renal tubules for Dogs 2 - 6 were around 4 times 
higher overall than those of the control dog (Table 2.2). Mean (95% CI) average 
number of damaged tubules over 60 fields (10X) for Dogs 2 – 6 was 0.127 (0.083 – 
0.017). The lowest average number of damage tubules (other than that of the 
control dog) was observed in Dog 5 (the dog that maintained a higher MAP during 
the ischaemia phase).  
 61 
 
 
 
For each urine sample on ELISA plate one, CV was < 15% between the two 
duplicate measurements; mean (95% CI) CV was 2.98% (2.28% – 3.69%) for 
duplicates. Of the 40 samples included in plate one, two returned no results, and 
their values were assumed to be out with the measureable range of the assay. Both 
of these samples were collected from Dog 4; one at 90 minutes following 
reperfusion and the other at 120 minutes following reperfusion. Nine samples 
measured < 4 pg mL
-1
 and so were below the measureable range of the assay 
(Table 2.3). Six samples measured> 400 pg mL
-1
 and so were above the 
measureable range of the assay (Table 2.3).  
When serial dilutions were analysed on Plate 2 it was found that two samples 
required a 1 in 400 dilution, and two required a 1 in 600 dilution, in order to obtain 
an NGAL concentration measurement of < 400 pg mL
-1
. There was large variation 
in NGAL concentration measurements between subsequent dilutions of the same 
urine sample until a concentration of < 400 pg mL
-1 
was reached. When NGAL 
concentration of a diluted sample was > 400 pg mL
-1
, mean (95% CI) CV between 
subsequent dilutions of the same sample was 18.88% (12.29 – 25.47). When 
NGAL concentration of a diluted sample was < 400 pg mL
-1
, mean (95% CI) CV 
between subsequent dilutions of the same sample was 4.73% (3.26 – 6.18). Of the 
four urine samples containing low NGAL concentrations that were analysed on 
plate two, dilutions of 1 in 25 or less produced samples containing NGAL 
concentrations within the assay’s measureable range of 4 – 400 pg mL-1. At these 
lesser dilutions, regardless of dilution there was wide variation in NGAL 
concentration measured between subsequent dilutions of the same urine sample, 
with mean (95% CI) CV between subsequent dilutions 34.25 (15.31 – 44.66). 
Taking into account uNGAL reported from Plate 1 and those measurements 
repeated at more appropriate dilutions on Plate 2, uNGAL appeared to be elevated 
with respect to baseline in four dogs during reperfusion (Table 2.3). Median (IQR) 
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uNGAL at baseline was 5.0 (4.0 – 9.5) ng mL-1. In three dogs uNGAL appeared to 
be elevated compared to baseline by 60-minute reperfusion (Dogs 1, 2 and 4), and 
in another dog uNGAL appeared elevated by 90-minute reperfusion (Dog 3).  
Urine NGAL concentration did not appear to be different when compared to 
baseline in the remaining two dogs (Dogs 5 and 6) (Table 2.3). Median (IQR) 
sNGAL at baseline was 29.3 (23.8 – 31.2) ng mL-1 and sNGAL was not elevated 
from baseline at either 60-minute or 120-minute reperfusion (Table 2.4).  
DISCUSSION 
Histopathological evidence of renal tubular damage was successfully demonstrated 
in all dogs subjected to 30 - 60 minutes of ischaemia and up to 120 minutes of 
reperfusion. Furthermore, calculation of the average number of damaged tubules 
across a set number of 10X fields allowed correct identification of was able to 
correctly identify true ischaemic tubular damage in the six dogs that underwent 
haemorrhage from changes associated only with autolysis in the control dog. The 
results indicated that the optimal model of I-R required to produce AKI to use for 
subsequent studies was maintenance of MAP of < 40 mmHg for 60 minutes 
followed by at least 120 minutes of reperfusion. 
As mentioned, most experimental animal studies investigating the 
pathophysiology, diagnosis, treatment and prevention of I-R AKI have utilised 
occlusion of renal vasculature to produce ischaemia. However, while a reduction in 
renal blood flow contributes to the development of I-R AKI during clinical 
situations such as anaesthetic-related hypotension and haemorrhagic shock, renal 
complete vascular occlusion is uncommon during veterinary surgery; thus the 
clinical relevance of these models is limited. Studies have shown that as well as 
tissue ischaemia subsequent to reduced renal perfusion, there are many other 
mechanisms involved in the development of tubular injury in these clinical 
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situations. Vascular congestion in the kidney during renal hypoperfusion has been 
found to produce more significant tubule injury than complete renal vascular 
occlusion (Moore et al. 2012). During shock, the activation of the sympathetic 
nervous system and altered plasma levels of hormones and cytokines exacerbate 
tubular injury (Chintala & Jandhyala 1990). The current model of haemorrhage 
induced renal hypoperfusion and subsequent I-R injury might therefore be expected 
to be more clinically relevant that the previous vascular occlusion models. The 
results of this pilot study support the use of this model in future studies.  
The ELISA had good performance in our laboratory as evidenced by well-fitting 
calibration curves and low CV values for duplicates. Validation and quality control 
data from the manufacturer states that the assay is reliable in detecting NGAL 
concentrations within a range of 4 – 400 pg mL-1. In order to stay within this range, 
several urine samples containing a high concentration of NGAL required dilution 
of a much higher magnitude than the 1:100 suggested by the manufacturer. The 
observation that variance between calculated NGAL concentration in different 
dilutions of the same urine sample was reduced to < 10% once measured NGAL 
was below 400 pg mL
-1
 supports this value being the upper limit of reliable 
measurement of this assay. Our results suggest that, to obtain accurate results, urine 
samples containing high NGAL concentrations in subsequent studies should be 
diluted to at least 1 in 800. High variance was noted between different dilutions of 
the same urine sample when low NGAL concentration was present. This is not un-
expected as any operator error will be amplified for samples containing low levels 
of a measured analyte. 
Urine NGAL concentration was elevated in four of the six dogs in which AKI was 
demonstrated by histological evidence of tubular damage. This elevation was 
evident by 60-minute reperfusion in three of the four dogs and by 90-minute 
reperfusion in the remaining dog. Urine was difficult to obtain in 50% of the dogs 
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at 30-minute reperfusion due to inadequate UOP. However, as none of the 30-
minute reperfusion urine samples showed any increase in uNGAL from baseline 
there is possibly no value in attempting to obtain samples at this early stage. 
Surprisingly, Dogs 5 and 6 showed a small decline in uNGAL between 60 and 120 
minutes of reperfusion. Dog 5 underwent less severe hypotension and also received 
the lowest tubular injury score, perhaps indicating that only mild renal injury was 
produced. However, Dog 6 underwent a full 60 minutes of MAP < 40mmHg with 
120 minutes of reperfusion, and had a higher average number of damaged tubules, 
refuting an explanation that the decrease in uNGAL in these dogs was due to 
milder AKI. A similarity between Dogs 5 and 6 was that HES, rather than gelatin, 
was used for intravenous fluid therapy during reperfusion. Of the four dogs (Dogs 
1 - 4) that showed an increase in uNGAL over time, three received gelatin and one 
hydroxyethyl starch. It was noted that urine samples obtained from all dogs during 
reperfusion became viscous and ‘sticky’, presumably due to high concentrations of 
these colloid - based solutions within the urine. This leads us to query a possible 
matrix effect of one or both of these colloid solutions, which could potentially 
explain variation in the magnitude of change in uNGAL between the dogs. Matrix 
effect refers to interference by constituents of the sample other than the analyte 
being measured on the response measured by the plate reader (NATA 2012). It is 
possible that the presence of either colloid solution could cross react with a stage of 
the immunoassay itself, or that they may affect the optical density of the ELISA 
plate wells during the plate reading process. 
Another explanation for the variation in uNGAL noted between the dogs 
following haemorrhage could be that values were not corrected for urine creatinine 
concentration. Several human clinical studies of uNGAL as a biomarker of AKI 
suggest that the UNCR should be used rather than absolute uNGAL in order to 
account for variation in urine dilution (Grenier et al. 2010; Delanaye et al. 2011). 
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However, it is also suggested that during times of rapidly changing glomerular 
filtration rate (i.e. acute hypotension followed by diuresis subsequent to 
reperfusion) urine creatinine concentration may not be an accurate marker of urine 
dilution (Ralib et al. 2012). The best solution may be to present both absolute 
NGAL concentration and UNCR in subsequent studies. 
A further explanation for variation in measured uNGAL between dogs could be the 
method of sample storage prior to analysis. Samples were stored on ice for up to 
two hours prior to centrifugation, and aliquots were then stored at -18
o
C to -20
o
C 
for up to 24 hours prior to storage at -80
o
C. To date there are no published studies 
investigating the stability of canine NGAL in urine at different storage 
temperatures. However, the effects of various storage temperatures on the stability 
of NGAL in human urine have been investigated. It was found that human NGAL 
is sufficiently stable in urine stored at 4
o
C for up to seven days, with < 2% change 
in NGAL concentration between days one and seven (Grenier et al. 2010). For 
longer term storage (months) however human urine samples are required to be 
stored at - 75
o
C as those stored at - 20
o
C showed significant decrease in their 
NGAL concentration (Bennett et al. 2008). Until data reporting the stability of 
NGAL in canine urine is presented, it may be advisable to store urine samples at 
temperatures of - 75
o
C or below for a maximum of 12 months. 
Serum NGAL concentration failed to increase over time in the four dogs in which 
it was measured. This is not particularly surprising, as it mirrors another study 
investigating NGAL as a biomarker of AKI in dogs (Lee et al. 2012). This finding 
may be related to the different in origin of sNGAL as compared to the NGAL that 
appears in the urine. Serum NGAL may be partly or wholly derived from non-renal 
origins (i.e. neutrophils and other organs), and so some authors have suggested that 
uNGAL may correlate better with AKI than sNGAL (Haase et al. 2011; Paragas et 
al. 2011). The lack of increase in sNGAL also suggests that systemic effects of 
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shock did not cause increases in NGAL of other sources and were also unlikely to 
contribute to changes in urinary NGAL.  
This pilot study provided encouragement that AKI in dogs can be achieved by 
acute haemorrhage to maintain MAP below 40mmHg for one hour followed by at 
least two hours of reperfusion. The renal tubular damage induced was clearly 
identifiable on histopathological examination as different to normal autolysis. The 
commercially available canine NGAL ELISA performed well within its 
recommended levels of measurement; however urine samples containing high 
NGAL concentrations required a much higher degree of dilution than suggested by 
the manufacturer. A significant increase in uNGAL was evident within 90 minutes 
of injury in 67% of dogs studied, although an increase in sNGAL was not 
observed. Inability to detect increases in all dogs may be due to potential matrix 
effects of colloid-base intravenous fluid solutions and this should be investigated as 
a potential bias during measurement of uNGAL before further animal studies are 
conducted. In addition, in future animal studies, all samples should be processed 
and frozen immediately to prevent degradation that might occur due to delayed 
sample processing.  
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FIGURES 
 
Figure 2.1 Calibration curves (4-parameter logistic curve) obtained from (a) 
ELISA Plate 1; r
2
 0.9996 (b) ELISA Plate 2; r
2
 0.9993. 
(a) 
 
(b) 
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Figure 2.2 Mean arterial pressure (mmHg) recorded every five minutes in 
six individual greyhound dogs undergoing an ischaemia-reperfusion model 
of acute kidney injury. Zero to 60 minutes: instrumentation, 60 – 120 
minutes: ischaemic phase, 120 – 240 minutes: reperfusion phase. Dogs 1, 2, 
and 6 underwent 60 minutes of reperfusion only. 
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TABLES 
 
Table 2.1 Signalment and anaesthetic data for six greyhound dogs that underwent haemorrhagic shock and fluid resuscitation during pilot investigations into 
a canine model of ischaemia-reperfusion acute kidney injury. Mean arterial blood pressure (MAP) measurements were made every five minutes during the 
haemorrhage phase. [SD; standard deviation]. 
 
Dog  Age (years) Weight (kg) Duration of 
haemorrhage 
phase 
(minutes) 
Volume of 
blood removed 
during 
haemorrhage 
(mL) 
Mean (SD) 
MAP during 
haemorrhage 
phase (mmHg) 
Duration of 
reperfusion 
prior to 
euthanasia 
(minutes) 
Type of colloid 
solution 
administered 
Hartmann’s 40 
mL kg
-1
 IV 
during 
reperfusion 
(yes / no) 
1 3 32 60 1825 33.2 (8.7) 60 Gelatin yes 
2 3 31.5 30 1350 23.0 (7.4) 60 Gelatin yes 
3 1.5 35 60 1350 26.9 (6.9) 120 HES yes 
4 2.5 30.5 60 1380 35.0 (5.6) 120 Gelatin no 
5 unknown 31 60 1640 43.6 (15.2) 120 HES no 
6 2.5 32.5 60 2003 34.5 (4.5) 120 HES no 
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Table 2.2 Average number of damaged tubules per 60 cortical fields (10X) for six greyhound dogs that underwent haemorrhagic shock and fluid 
resuscitation during pilot investigations into a canine model of ischaemia-reperfusion acute kidney injury, and of one normal control greyhound dog that had 
not undergone the acute kidney injury model 
 
Dog # 
Average number of damaged tubules - 
right kidney  
Average number of damaged tubules - 
left kidney 
Average number of damaged tubules - 
Overall  
1 - - - 
2 0.2 0.05 0.125 
3 0.1 0.08 0.09 
4 0.2 0.22 0.21 
5 0.12 0.05 0.085 
6 0.05 0.2 0.125 
Control 0.03 0.03 0.03 
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Table 2.3 Urine NGAL concentration (uNGAL) and tubular injury scores from greyhound dogs that underwent haemorrhagic shock and fluid resuscitation 
during pilot investigations into a canine model of I-R AKI. - No sample obtained due to poor urine output. Where measured NGAL concentration of a diluted 
sample from ELISA Plate 1 (1:100 dilution) was >400pg mL
-1
 or <4.0 pg mL
-1
, the concentration of the sample is reported as > 40 ng mL
-1
 or <4.0 ng mL
-1. † 
Urine NGAL concentration measured when sample was diluted 1 in 1600 (ELISA Plate 2). ‡ Urine NGAL concentration measured when sample was 
undiluted (ELISA Plate 2). 
 
Dog # uNGAL Pre-
anaesthesia  
(ng mL
-1
) 
uNGAL 30-minute 
reperfusion  
(ng mL
-1
) 
uNGAL 60-minute 
reperfusion  
(ng mL
-1
)  
uNGAL 90-minute 
reperfusion  
(ng mL
-1
) 
uNGAL 120-minute 
reperfusion  
(ng mL
-1
) 
Tubular injury 
score 
1 6.00 < 4.0 > 40   - 
2 12.83 - > 40 
177.96† 
  0.125 
3 10.67 - 7.00 > 40 > 40 0.09 
4 < 4.0 < 4.0 > 40 
152.37† 
 
433.17† 
 
439.79† 
0.21 
5 < 4.0 < 4.0 < 4.0 
0.19‡ 
 < 4.0 
0.22‡ 
0.085 
6 < 4.0 - 4.35  < 4.0 
0.38‡ 
0.125 
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Table 2.4 Serum NGAL concentration (sNGAL) from greyhound dogs that underwent haemorrhagic shock and fluid resuscitation during pilot investigations 
into a canine model of I-R AKI. 
 
Dog # sNGAL Pre-anaesthesia  
(ng mL
-1
) 
sNGAL 60-minute reperfusion  
(ng mL
-1
) 
sNGAL 120-minute reperfusion  
(ng mL
-1
) 
2 27.78 20.87 n/a 
4 30.87 37.53 31.47 
5 32.30 20.01 17.18 
6 11.73 17.83 12.01 
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CHAPTER 3 - INVESTIGATION OF 
INTERFERENCE FROM SYNTHETIC 
COLLOIDS ON THE PERFORMANCE OF A 
CANINE NEUTROPHIL GELATINASE-
ASSOCIATED LIPOCALIN IMMUNOASSAY 
 
INTRODUCTION 
Measurement of NGAL concentration in canine urine has recently gained interest 
as part of the search for an early biomarker of AKI (De Loor et al. 2013).  
Veterinary studies using a commercially available canine NGAL ELISA show that 
uNGAL is increased in canine patients with AKI when compared to those without 
renal disease (Segev et al. 2013; Steinbach et al. 2014).  
As described in Chapter Two, the authors encountered a large degree of variation 
in measured urine NGAL concentration between individual dogs undergoing a 
haemorrhage-based model of I-R AKI. The type of fluid administered in order to 
produce reperfusion was not standardized between dogs and included an isotonic 
crystalloid solution, a gelatin-based colloid solution or a hydroxyethyl starch. A 
subjective increase in viscosity was noted for the urine of dogs that had received 
the colloid solutions.  
Fluid therapy is one of the mainstay treatments for AKI in both veterinary and 
human patients, both as specific treatment (i.e. restoration of tissue perfusion 
subsequent to ischaemic AKI) and supportive in order to maintain appropriate 
hydration, acid-base and electrolyte status (Ross 2011). Fluid therapy may involve 
the use of synthetic colloid solutions, especially for volume expansion during the 
very early stages of AKI. Synthetic colloids are polydisperse macro-molecular 
solutions including gelatin-based solutions, starches and dextrans. These solutions 
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effectively increase intravascular volume as their high molecular weight allows 
them to both retain and draw water into the vascular space (Mensack 2008). 
Synthetic colloids are eliminated from the body in the urine. Gelatin-based colloids 
contain molecules of a lower molecular weight that can be filtered by the 
glomerulus, whereas starch based solutions tend to contain larger molecules that 
must first undergo hydrolysis by plasma enzymes prior to renal elimination 
(Jungheinrich et al. 2002).  
Given that the synthetic colloids are commonly used in the management of 
veterinary patients with AKI; it is highly likely that many urine samples obtained 
from animals with, or at risk for, AKI will contain some colloid within their matrix. 
It has been shown that as long as some urine production is present, patients with 
renal failure are still capable of renal excretion of the synthetic colloid, 
hydroxyethyl starch (Jungheinrich et al. 2002).  
When establishing an immunoassay for use in a specific setting it is important to 
rule out any pre-analytical or analytical error, due to the presence of interfering 
substances within the sample. Interference may be described as any factor causing 
bias in an assay result, other than the presence of a true cross-reacting substance 
(Davies 2013). Interfering substances that may be found in the sample matrix are 
either endogenous (i.e. naturally occurring substances such as lipids, proteins and 
haemoglobin) or exogenous (i.e. drugs, toxins, storage effects and sample 
additives) (Dimeski 2008). These “matrix effects” can affect the performance of an 
immunoassay in the following ways: alteration of the effective analyte 
concentration, interference with antibody binding, interference with the binding of 
the capture antibody to the solid phase, interference in the separation stage, or 
interference with the spectrophotometric measurement (Davies 2013). Interference 
results in a falsely high or low measurement of analyte concentration. The 
magnitude of this effect usually depends on the concentration of the interfering 
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substance (Tate & Ward 2004). Immunoassays exposed to interference also may 
fail to display linearity when serial dilutions are performed (Systems ; Tate & 
Ward 2004). Commercially available ELISAs undergo rigorous testing by the 
manufacturer to ensure there is no interference from many of the commonly 
recognized endogenous culprits; however some exogenous substances unique to a 
particular clinical setting or situation may not previously have been investigated. 
Hence, it is important to rule out any interference from the presence of synthetic 
colloids on sample matrix prior to the use of immunoassays to investigate the 
usefulness of potential biomarkers for AKI.  
The aim of the present study was to investigate effects of two different synthetic 
colloid solutions; 4% succinylated bovine gelatin and 6% hydroxyethyl starch for 
potential interference with a commercially available dog NGAL ELISA. Following 
the variation noted in Chapter 2 it was theorized that the presence of synthetic 
colloid in the sample matrix could interfere with the performance of the assay. 
Effect of synthetic colloid on the assay could take the form of interference of signal 
measurement or direct/indirect interference with antibody-antigen binding.  
METHODS 
PART (I) ASSESSMENT OF INTERFERENCE WITH LIGHT 
ABSORBANCE DURING SPECTROPHOTOMETRIC MEASUREMENT 
 
The effect of various concentrations of each colloid solution on mean absorbance 
measured via spectrophotometry was investigated. Samples tested included A) an 
undiluted sample of normal canine urine and the following solutions consisting of 
varying dilutions of urine with colloid; B) 1:3 urine: 4% succinylated bovine 
gelatin solution (Gelofusine®, B Braun Australia Pty Ltd, Australia [GEL]), C) 1:1 
urine: GEL, D) 3:1 urine: GEL, E) 1:3 urine: 6% hydroxyethyl starch (Voluven®, 
Fresenius Kabi Australia Pty Ltd, Australia [HES]), F) 1:1 urine: HES, G) 3:1 
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urine: HES. Each of the six solutions, and the un-spiked urine (solution A), were 
then diluted to 1 in 100 using sample diluent. 200 μL of each of the seven solutions 
was then pipetted into 12 different wells of a clean 96-well ELISA plate. Solutions 
were allocated to wells in a manner such that each solution was measured at both 
the top, bottom, left and right of the plate in order to account for any drift during 
measurement. The optical density (absorbance) of each well was read at 450 nm 
using an ELISA plate reader (iMark™ Microplate Absorbance Reader, Bio-Rad 
Laboratories, USA).  The mean absorbance of each solution was calculated as the 
average absorbance of each well containing that solution. One – way analysis of 
variance was used to determine differences in absorbance between the seven 
solutions. Where there was a significant effect at p < 0.05 post hoc testing using 
Tukey’s multiple comparisons test was used to determine which solutions differed. 
An adjusted p value of < 0.05 was considered significant.  
(II) ASSESSMENT OF THE EFFECT OF LINEAR DILUTION 
To assess for interference with the performance of the Bioporto® Dog NGAL 
ELISA due to synthetic colloid presence in the sample matrix, a standard solution 
of NGAL was linearly diluted with various colloid solutions.  Expected and 
observed concentrations were compared. Standards were prepared as follows: 200 
μL of the 400 pg mL-1 NGAL ELISA kit calibrator solution was added to either 
200 μL of kit sample diluent (Bioporto® Dog NGAL Kit sample diluent solution; 
prepared as instructed by manufacturer) to produce solution A, or 200 μL of each 
of six colloid solutions to create solutions B - G containing 200 pg mL
-1
 of NGAL 
(i.e. a 1:2 solution). The six colloid solutions were: B) 1:3 sample diluent: GEL, G) 
1:1 sample diluent: GEL, C) 3:1 sample diluent: GEL, E) 1:3 sample diluent: HES, 
F) 1:1 sample diluent: HES, B) 3:1 sample diluent: HES. The seven NGAL spiked 
solutions were then serially diluted using the same (un-spiked) solution as diluent, 
to 1:4, 1:8, 1:16 and 1:32. The dog NGAL ELISA was then performed as described 
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previously (Chapter 2). The absorbance values of the kit calibrators were used to 
create a calibration curve using linear x and y axes with 4-parameter logistic curve 
fitting. All standards and samples were run in duplicate, and samples with a high 
duplicate error (CV >15%) were rejected. Linearity was then assessed for each 
serial dilution by calculating recovery where % recovery = [observed value / (value 
of previous dilution * dilution factor)] *100. Dilutions were assessed as being 
linear where recoveries fell between 80 – 120%.  
RESULTS 
PART (I) 
The mean (±SD) absorbance values for each of the seven solutions were: solution 
A 0.116 (±0.022), solution B 0.097 (±0.028), solution C 0.094 (±0.020), solution D 
0.095 (±0.015), solution E 0.088 (±0.019), solution F 0.090 (±0.013) and solution 
G 0.097 (±0.024). Mean absorbance values for solution A were significantly higher 
than those for solution E (p = 0.0137) and solution F (p = 0.0448). Mean 
absorbance between all other solutions were similar. 
PART (II) 
Recovery values ranged from 90.6 – 113.8% for all solutions at dilutions of 1:8 or 
less (Table 3.1). For solutions of 1:16 dilution recovery was < 80% for all GEL 
solutions, and for solutions E (1:3 sample diluent: HES) and G (3:1 sample diluent: 
HES). For 1:32 dilutions, all solutions returned recoveries of < 80% (Table 3.1). 
DISCUSSION 
The findings of this study do not support the presence of significant interference 
from the synthetic colloid 4% succinylated bovine gelatin on the dog NGAL 
ELISA investigated. A difference in mean absorbance measured in Part (I) for 
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urine compared to the two most concentrated HES solutions suggests that there 
may be a small amount of interference from 6% hydroxyethyl starch during 
spectrophotometry. Spectrophotometry is a method of quantifying colourimetric 
change by measuring the amount of light absorbed by a solution at a specific 
wavelength. For a ‘normal’ solution, Beer-Lambert’s law reveals a direct 
correlation between light absorbance of a molecule and its concentration, provided 
path length remains constant (Upstone 2000). Deviation from Beer-Lambert’s law 
or a change in path length could lead to erroneous concentration measurement.  It 
is possible, though unlikely, that were any colloid incompletely washed from the 
ELISA microplate prior to spectrophotometry it could cause such a deviation. 
Potentially, the addition of GEL or HES to the solution contained in a well of the 
microplate could lead to variation in path length, for instance if foaming tendency 
were higher with the colloid due to altered surface tension or due to alteration of 
the shape of the meniscus. Additionally, any alteration to the pH of a solvent can 
result in changes to molecular electron distribution and hence change that 
molecule’s absorbance spectrum (Upstone 2000). The GEL solution used in our 
study has a pH of 7.4 ± 1.3, whereas the HES solution has pH 4.0-5.5. It is possible 
that the lower pH of HES was responsible for the different mean absorbance 
observed with that solution in this experiment. The significance of the difference in 
mean absorbance witnessed in Part (I) on the performance of an ELISA is 
unknown; in this experiment the wells contained only sample and therefore a high 
concentration of diluent and colloid. In reality an ELISA plate would undergo 
several wash stages following addition of sample by the time spectrophotometry 
were performed, hence the concentration of colloid remaining in the wells would 
be much lower than that tested here and so the impact of HES on the mean 
absorbance measurement would be expected to be insignificant. 
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Potential methods for synthetic colloid solutions interfering with the antibody 
binding stage of the immunoassay include direct interference with antibody: 
antigen binding, or indirect interference. Direct interference is unlikely given that 
the proteins present in the colloid solutions are not binding proteins, reactive 
antibodies or autoantibodies, and do not structurally resemble NGAL. However, 
possible mechanisms by which synthetic colloids could interfere with antibody 
binding include: physical masking of the antibody coating of the plate, or alteration 
of antibody binding site conformation though changes in ionic strength or pH of 
the reaction medium (Davies 2013). Potential methods of indirect interference by 
synthetic colloids include: incomplete washing leading to sample carry-over, 
increased risk of pipetting error, or interruption of proper mixing of solutions. 
Presence of synthetic colloid makes sample matrix more viscous; this can lead to 
pipetting error due to an increased foaming tendency (i.e. tiny bubbles in the 
pipette tip lead to a smaller than anticipated volume being dispensed) or due to 
failure of all liquid to leave the pipette tip (Koivisto 2009). In assessment of 
linearity during serial dilution experiments recovery of 80-120% is considered 
acceptable. Recovery was within this acceptable range for all solutions at the 1:2, 
1:4 and 1:8 dilutions. However at 1:16 all GEL solutions and two HES solutions 
gave recoveries <80%. This could suggest some interference from the synthetic 
colloids at these lower NGAL concentrations, however it is difficult to explain why 
recovery remained >80% for the 1:1 HES solution at this dilution if this were the 
case. At 1:32 solution recovery was very poor across all solutions, including kit 
sample diluent. The most likely explanation is that at this low dilution some of the 
NGAL concentrations measured were below 4 pg mL
-1
 which is the low end of the 
measurable range of the assay. Pipetting error also becomes more important at low 
dilutions, so the poor recovery could indicate problems with pipetting technique 
unrelated to the presence of synthetic colloid. 
 83 
 
 
 
The concentration of colloid molecules in the urine of dogs following fluid 
resuscitation with synthetic colloid fluids in Chapter 2 could not be determined. 
Thus, it is not possible to know if the concentrations of the colloid solutions used in 
the in vitro experiments were an accurate representation of the urine 
concentrations. It is anticipated that concentration of colloid molecules was high as 
the urine became visibly viscous following administration of 20 mL kg
-1
 of each 
colloid intravenously. As the concentration was not known, testing for interference 
was performed on a range of concentrations, in attempt to capture the likely 
concentration within the urine.  
A limitation to this study is that a full spiking-recovery study was not performed. It 
has been recommended that in addition to assessment of linearity during serial 
solutions, recovery studies are also performed whereby low, medium and high 
concentrations of the analyte to be measured are spiked into samples containing the 
matrix being examined for interference (Tate & Ward 2004). To improve the 
validity of our study it would have been optimal to spike multiple different samples 
containing each synthetic colloid with three different known concentrations of 
NGAL. 
To conclude, this study found no evidence of significant interference on the 
performance of a commercially available canine NGAL ELISA by a 4% 
succinylated bovine gelatin solution. A 6% hydroxyethyl starch solution produced 
some variation in mean absorbance during spectrophotometry; however the 
relevance of this during performance of the ELISA is expected to be minimal. 
Recovery from all solutions containing 6% hydroxyethyl starch was poor at 
dilutions of more than 1:16 onwards, however this is likely to be a result of poor 
assay performance due to diluted samples containing NGAL concentrations below 
the measurable range of the assay. Based on these results, gelofusine may be the 
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preferred fluid for resuscitation in future studies investigating changes in uNGAL 
in a canine I-R model.  
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TABLE 
 
Table 3.1. Assessment of linearity of neutrophil gelatinase-associated lipocalin (NGAL) concentration measured using a commercial dog NGAL enzyme-
linked immunoassay during serial dilutions of a canine urine sample with solutions containing varying concentrations of synthetic colloids; 4% gelatin (GEL) 
or 6% hydroxyethyl stach (HES). † recovery falls outwith acceptable range of 80 – 100%. 
  Solution A 
100% Diluent 
Solution B 
1:3 diluent: GEL 
Solution C 
1:1 diluent: GEL 
Solution D 
3:1 diluent: GEL 
Solution E 
1:3 diluent: HES 
Solution F 
1:1 diluent: HES 
Solution G 
3:1 diluent: HES 
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1:2 200 208.8 104.4 218.7 109.3 209.2 104.6 227.3 113.6 214.2 107.1 217.1 108.5 227.5 113.8 
1:4 100 102.3 98.0 115.2 105.4 124.1 118.6 102.9 90.6 103.3 96.4 112.3 103.4 112.1 98.6 
1:8 50 46.8 91.5 60.5 105.1 58.8 94.8 54.7 106.4 51.5 99.6 52.0 92.7 53.3 95.0 
1:16 25 21.9 93.6 23.8 78.7† 21.6 73.3† 17.2 63.0† 15.3 59.5† 21.1 81.0 19.6 73.6† 
1:32 12.5 3.9 35.9† 3.2 27.3† 6.2 57.5† 4.8 56.2† 1.2 15.7† 3.2 26.0† 2.8 22.4† 
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CHAPTER 4 – INVESTIGATION OF 
CANINE URINARY NEUTROPHIL 
GELATINASE-ASSOCIATED LIPOCALIN 
CONCENTRATION DURING AN 
ISCHAEMIA-REPERFUSION MODEL OF 
ACUTE KIDNEY INJURY 
 
INTRODUCTION 
Acute kidney injury, a common syndrome in human and veterinary medicine, can 
be caused by I-R injury subsequent to renal hypoperfusion during general 
anaesthesia (Moore et al. 2012; Behrend et al. 1996; Mugford et al. 2013).  Four 
sequential stages of AKI have been identified: initiation, extension, maintenance 
and recovery (Mugford et al. 2013; Devarajan 2006; Basile et al. 2012). Animal 
studies have shown that therapeutic interventions to reverse or prevent further 
progression of AKI must occur during the initiation or extension phases
 
(Devarajan 
2006). Unfortunately, AKI diagnosis and staging to date has relied upon indicators 
of glomerular filtration deficiency (e.g. sCr, UOP) that do not change significantly 
until the maintenance phase, two to three days following initiation of injury
 
(Basile 
et al. 2012). Late diagnosis and delayed intervention contribute to the high 
mortality and morbidity associated with AKI (Moore et al. 2012; Basile et al. 
2012). 
Early diagnosis of AKI may be possible by measuring the urine concentration of 
NGAL, a biomarker of renal tubular injury. Urine NGAL concentrations are 
increased two hours following initiation of I-R AKI in rodent models using uni- or 
bi-lateral renal occlusion (Mishra et al. 2003; Mori et al. 2005). Clinical studies in 
people placed on cardiopulmonary bypass demonstrate increases in uNGAL within 
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two hours of renal I-R (Bennett et al. 2008; Mishra et al. 2005). While clinical 
studies in dogs report increases in uNGAL 12 hours after injury (Lee et al. 2010; 
Steinbach et al. 2014), whether or not uNGAL can detect tubular injury in dogs at 
earlier time points is unknown. 
The aim of the current study was to document uNGAL changes in anaesthetised 
dogs using a model of renal I-R produced by experimental haemorrhage and fluid 
resuscitation. We hypothesised that the model would produce histological evidence 
of renal tubular damage and that uNGAL would increase from baseline within 
three hours of renal hypoperfusion. 
METHODS 
ANIMALS AND SELECTION CRITERIA 
Seven donated adult entire male greyhound dogs, median (range) body weight 33 
(30-35) kg, scheduled to be used as terminal blood donors were included in the 
study.  Physical examination, renal ultrasonography, urinalysis, complete blood 
count, and sCr, BUN and serum albumin concentrations for all dogs were within 
reference intervals previously reported for healthy adult greyhounds (Zaldivar-
Lopez et al. 2011). Ethics approval was granted by the Murdoch University Animal 
Ethics Committee (permit number R2586/13) and the dogs cared for according to 
the ‘Australian code for the care and use of animals for scientific purposes’. 
ANAESTHESIA 
Dogs were fasted for at least eight hours prior to the procedure.  Ad lib water 
access was provided until premedication. Intramuscular methadone 0.3 mg kg
-1
 
(Ilium Methadone 10 mg mL
-1
, Troy Laboratories Australia) was administered 30 
minutes prior to induction of general anaesthesia using IV alfaxalone (Alfaxan 
injection 10 mg mL
-1
, Jurox, Australia) 1.7 - 2.2 mg kg
-1
. Following orotracheal 
intubation, dogs were positioned in left lateral recumbency. Anaesthesia was 
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maintained with isoflurane (I.S.O., VCA, Australia) delivered in an oxygen and 
medical air mix (30% inspired fraction of oxygen), via a circle system. End tidal 
isoflurane was maintained at 1.3 – 1.4% (1 x MAC) (Steffy & Howland 1977; 
Valverde et al. 2003). Hartmann’s solution (Compound Sodium Lactate, Baxter 
Healthcare, Australia) 10 mL kg
-1
 hour
-1
 IV and fentanyl (Fentanyl injection 50 µg 
mL
-1
, AstraZeneca, NSW, Australia) 2 µg kg
-1
 hour
-1 
IV were administered 
throughout anaesthesia. The fentanyl infusion provided additional analgesia, 
particularly at end of study when the effects of the methadone premedication 
and femoral nerve might begin to wane. Mechanical ventilation was performed 
to maintain normocapnia (arterial carbon dioxide tension 35-45 mmHg) using a 
volume-controlled time-cycled veterinary anaesthesia ventilator (Model TH-1, 
Beijing Read Eagle Technology Co Ltd, China). Active warming maintained 
oesophageal temperature between 36.5 – 37.5oC.  
INSTRUMENTATION  
A 12 gauge 13 cm cannula (Angiocath; Becton Dickinson Infusion Therapy 
Systems Inc.; USA) was inserted into the cranial vena cava via the right jugular 
vein for collection of blood samples and injection of lithium chloride. The left 
femoral artery was cannulated (20 gauge 3 cm Angiocath; Becton Dickinson 
Infusion Therapy Systems Inc.; USA) to facilitate measurement of mean arterial 
pressure (MAP), measurement of lithium chloride voltage for cardiac output (Qt) 
calculation and removal of blood to generate experimental haemorrhage. A nerve 
stimulation-guided (Innervator 272; Fisher & Paykel Health Care; New Zealand) 
femoral nerve block was performed at the femoral triangle with bupivacaine (0.1 
mL kg
-1
; Bupivacaine hydrochloride 50 mg mL
-1
; Pfizer, NSW, Australia), before 
the femoral artery was surgically exposed and a 14 gauge 9 cm cannula 
(Angiocath; Becton Dickinson Infusion Therapy Systems Inc.; USA) inserted. The 
femoral artery cannula was connected by heparinised saline filled non-distensible 
 91 
 
 
 
tubing to a pressure transducer (DTX Plus, Argon Critical Care Systems, 
Singapore) interfaced with a multi-parameter monitor (Surgivet V9203; Smiths 
Medical, USA). Transducer accuracy was verified by calibration with a mercury 
manometer at 40, 80 and 120 mmHg prior to use in each animal. After 
instrumentation, the transducer was positioned at the level of the right atrium (level 
with the manubrium of the sternum) and zeroed to atmospheric pressure. A rapid 
flush test was performed to assess the damping factor subjectively. At the end of 
each study the transducer was opened to the atmosphere to confirm absence of 
baseline drift. An 8Fr 55cm urinary catheter (Foley urinary catheter; Smiths 
Medical, USA) was inserted into the bladder for collection of urine samples and 
measurement of UOP. After instrumentation, which occurred within the first 30 
minutes of anaesthesia, the dog was repositioned in dorsal recumbency. 
 
EXPERIMENTAL DESIGN 
Ischaemia was produced by removing sufficient blood volume via the femoral 
arterial catheter to maintain MAP ≤ 40 mmHg for 60 minutes. Total blood volume 
removed from each dog was recorded. Reperfusion was produced by maintaining 
MAP ≥ 60 mmHg for three hours via administration of IV succinylated gelatine 
solution 4% (Gelofusine, B Braun, Australia). Initially 20 mL kg
-1
 was 
administered at 1200 mL h
-1
, and additional colloid administered as required. Total 
volume of colloid administered was recorded. Following the reperfusion period, 
dogs were euthanised using pentobarbitone (Lethabarb Euthanasia Injection 300 
mg ml
-1
, Virbac, Australia) 150 mg kg
-1
 IV.   
 
DATA COLLECTION 
Data collection was performed at five time points: T0 (baseline) = 60 minutes after 
induction of anaesthesia and before haemorrhage; T1 = 60 minutes from the time 
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MAP reached ≤40 mmHg; T2 = at one hour, T3 = at two hours and T4 = at three 
hours after fluid resuscitation achieved a MAP > 60 mmHg.  
At each time point, 5 consecutive measurements of MAP were recorded and the 
mean MAP was calculated. Arterial and central venous (cranial vena cava) blood 
was collected into commercial pre-heparinised syringes (PICO syringe; 
Radiometer, Denmark) and processed immediately for arterial and central venous 
oxygen tension (PaO2 and PcvO2 respectively), sodium concentration (Na
+
), 
haemoglobin concentration (Hb) and arterial and central venous oxygen saturation, 
using an in-house blood gas analyser and co-oximeter (ABL 725, Radiometer, 
Denmark). 
Cardiac output was measured by lithium dilution technique (Mason et al. 2001). 
For each Qt measurement at T0 and T1, 0.15 mmol (1 mL) lithium chloride was 
administered. At T2 – T4, 0.3 mmol (2 mL) lithium chloride was administered for 
accurate measurement during the high Qt state observed during reperfusion. Two 
Qt measurements were performed within 5 minutes at each time point. Duplicate 
measurements were repeated if the two measurements were disparate by >10%  
Blood was obtained from the jugular vein catheter at each time point and serum 
stored at -80
0
C for later SCr measurement (AU 480; Beckman Coulter; USA). 
All urine was collected, and UOP recorded at each time point. Urine was 
immediately centrifuged at 250 g for 5 minutes. Cytospin preparations of urine 
sediment were air-dried and stained with Wright’s stain before examination using 
light microscopy at low (x100) and high (x400) power. Urine sediment 
examination was performed on a minimum of 10 high power fields. Urine 
creatinine concentration was measured for each sample. Remaining urine 
supernatant was divided into aliquots for storage at -80
o
C. 
Kidneys were removed from all dogs and 5 – 7 mm thickness cortico-medullary 
sections taken from the centre of each kidney were placed in 10% formalin within 
10 minutes after euthanasia. Samples were processed routinely, embedded in 
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paraffin, sectioned at 3µm thickness and stained with haematoxylin and eosin and 
periodic acid-Schiff. One veterinary pathologist, unaware of the results of the 
biomarker analysis, examined the sections by light microscopy. Twenty cortical 
fields (20X) from each kidney were chosen at random (by moving the microscope 
to a new field while not observing the section through the oculars) and then 
assessed for the presence of tubular damage. Tubular damage was defined as 
presence of epithelial cells undergoing vacuolar degeneration or tubules with intra-
luminal detached necrotic cells. The average number of damaged tubules per fields 
across both kidneys was calculated for each dog.  
Urine NGAL concentration was determined using a commercially available 
enzyme linked immunoassay (ELISA) validated for use in the dog (Dog NGAL 
ELISA Kit, BioPorto Diagnostics, Denmark) performed according to the 
manufacturer’s instructions. Sample diluent provided was used to create a 1:1000 
dilution of each urine sample. Each sample was analysed in duplicate and the mean 
of the two measurements recorded. If the coefficient of variation of the mean 
absorbance of two duplicates was >15%, the result was discarded and the sample 
re-analysed in duplicate. The measureable range of the assay as reported by the 
manufacturer is 4 – 400 pg mL-1. Concentrations greater or less than this range 
were assigned 4 pg mL
-1
 or 400 pg mL
-1
, respectively.   
 
STATISTICAL ANALYSIS 
To determine presence and then resolution of shock present after haemorrhage and 
following reperfusion, OER was calculated. This first required calculation of body 
surface area, cardiac index (CI), oxygen delivery (DO2I), and oxygen consumption 
(VO2I ) (Appendix 1). Severe shock was defined as OER > 0.5 (Gutierrez et al. 
1986; Samsel et al. 1988; Cilley et al. 1989). In addition urine NGAL:creatinine 
concentration ratio (UNCR) were calculated (Appendix 1). Haemodynamic and 
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uNGAL data were tested for normality using a Shapiro-Wilk normality test and 
parametric data described as mean and 95% confidence interval (CI). Where the 
calculation of the 95% CI resulted in a negative lower confidence limit, the limit 
was reported as zero. Repeated measures one-way ANOVA was used to determine 
change in OER, sCr, uNGAL and UNCR over time. Where there was a significant 
effect at p < 0.05, post hoc testing using Dunnett’s test for multiple comparisons to 
baseline was performed with an adjusted p < 0.05 considered significant. The fold 
change from baseline at T3 and T4 was calculated by dividing the difference 
between uNGAL (or UNCR) at T3 or T4 by the uNGAL (or UNCR) at T0. The 
95% CI of the fold change was also calculated. 
RESULTS 
Mean (95% CI) volume of blood withdrawn to achieve MAP ≤40 mmHg for 60 
minutes was 53 (48 – 57) mL kg-1 (Fig. 1). Oxygen extraction ratio after 60 minutes 
of hypotension (T1) was significantly elevated from T0 (p < 0.0001), however 
OER was > 0.5 in only 6 dogs, and 0.44 in the remaining dog (Table 1).  Mean 
(95% CI) volume of succinylated gelatin solution required to maintain MAP ≥60 
mmHg was 23 (20 – 26) mL kg-1. Administration of gelofusine was accompanied 
by a decrease in OER at T2 and T3 to values not significantly different from 
baseline OER. 
 
Serum creatinine concentration was increased when compared to baseline (T0) 
after 60 minutes of hypotension (T1) (p < 0.0001) and remained elevated at T2 (p < 
0.0001), T3 (p < 0.0001) and T4 (p = 0.005) (Table 1). 
 
Urine output of <1 mL kg
-1
 hour
-1
 (oliguria) occurred at T1 and T2, with small 
increases in UOP at T3 and T4 (Table 1). Urine sediment examination of one dog 
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revealed presence of degenerate neutrophils at T1 – T4. Neutrophils were not 
present in urine of any other dog at any time point.  
The NGAL concentration for all 1:1000 dilutions fell below the upper end of the 
measurable range of the ELISA. The NGAL concentration for 7 samples (two at T0 
and five at T1) was below the lower end of the measurable range of the ELISA and 
recorded as 4 pg mL
-1
.  
Urine NGAL concentration was significantly elevated compared to baseline (T0) at 
T3 (p = 0.016) and T4 (p = 0.046) (Table 1). Mean (95% CI) uNGAL fold increase 
was 24.2 (7.3 – 41.0) at T3 and 18.1 (4.7 – 31.5) at T4. Urine NGAL:creatinine 
ratio was significantly elevated compared to baseline (T0) at T3 only (p = 0.005) 
(Table 1). Mean (95% CI) fold increase in UNCR was 41.1 (10.8 – 71.4) at T3 and 
24.5 (3.7 – 45.2) at T4. 
Urine NGAL concentrations at T0 and T1 from one dog (Dog F) were considerably 
higher (10x) than of other dogs. Statistical analysis was performed with and 
without data from this dog (Table 2).  
When dog F was excluded from data analysis, uNGAL was significantly elevated 
compared to baseline (T0) at T3 (p = 0.021) and T4 (p = 0.039) (Table 2). Mean 
(95% CI) uNGAL fold increase was 27.9 (10.4 – 45.5) at T3 and 21.0 (6.7 – 35.3) 
at T4. Urine NGAL: creatinine ratio was significantly elevated compared to 
baseline (T0) at T3 only (p = 0.015) (Table 2). Mean (95% CI) fold increase in 
UNCR was 47.3 (14.7 – 80.0) at T3 and 28.3 (5.2 – 51.4) at T4. 
Renal tubular damage was evident in both kidneys from all dogs on histologic 
examination (Fig. 2).  Lesions were identified in the proximal tubule, 
predominantly at the tubulo-glomerular junction and included vacuolated cells, 
intra-tubular detached necrotic cells or cellular debris and attenuated epithelial 
cells. The average number of damaged tubules within a 20x magnified high power 
field for all dogs ranged from 1 to 20 (median 3). Histopathology scores for all 
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dogs are displayed alongside fold change in uNGAL and UNCR at T3 and T4 in 
Table 3. 
 
DISCUSSION 
 
This study determined uNGAL and UNCR changes during an I-R model designed 
to simulate renal hypoperfusion and reperfusion secondary to intra-operative 
haemorrhage and subsequent fluid resuscitation. Histology confirmed that the 
model successfully produced acute tubular damage
 
(Devarajan 2010). The results 
confirmed increases in uNGAL and UNCR from baseline within two hours of 
reperfusion by 28-fold and 47-fold, respectively. 
Changes in uNGAL produced by this clinically relevant model of acute ischaemic 
tubular injury are consistent with those from rodent vascular occlusion models and 
human clinical studies. Increased uNGAL within two hours of acute tubular 
ischaemia occurred in experimental studies using renal vascular clamping models 
of ischaemic AKI in rodents
 
(Mishra et al. 2003). Increased uNGAL and UNCR 
were also reported within one hour of ischaemic insult in human patients who 
developed AKI subsequent to cardiac surgery. Following cardiopulmonary bypass, 
uNGAL increased by almost 100-fold in children within two hours, and by 40-fold 
in adults within one hour (Mishra et al. 2005; Wagener et al. 2006). 
The current study reports changes in both uNGAL and UNCR. It is suggested that 
measuring UNCR avoids variation in uNGAL caused by altered urine 
concentration in subjects with a steady state glomerular filtration rate (Goldstein 
2010; Grenier et al. 2010). However, normalisation to urine creatinine 
concentration assumes constant urinary creatinine excretion in an individual over 
time, and between individuals, a requirement unlikely to be met during AKI 
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(Waikar et al. 2010; De Loor et al. 2013). Due to controversy in this area, it was 
decided to report both uNGAL and UNCR in the current study. 
Of note, uNGAL in one dog (Dog F) was initially higher compared with the other 
dogs. This finding created difficulty in analysis since it substantially skewed data at 
early time points. With a small sample size, it cannot be known if this dog 
represents normal variation or a spurious finding. It is unlikely that pre-existing 
renal disease was present given a normal pre-anaesthetic assessment and lack of 
changes consistent with chronic renal disease on histology. The UNCR was also 
higher at baseline for this dog; meaning more concentrated urine was unlikely to 
have produced the observed increased uNGAL. Wide variation in baseline uNGAL 
for healthy people has created difficulty in determining a reference interval leading 
to suggestion that magnitude of uNGAL change from baseline is more appropriate 
than a single measurement (Smertka & Chudek 2012; Clerico et al. 2012). 
Statistical analysis with and without data from this dog was still able to detect 
increases in NGAL during our study, supporting the usefulness of the biomarker 
for detecting AKI when baseline measurements were available. However, further 
work is required to determine usefulness in clinical practice where a baseline 
sample is frequently not available.  
Our study also revealed variation in magnitude of uNGAL and UNCR increase 
from baseline following I-R injury. Variation in uNGAL and UNCR measurements 
between individual dogs with AKI in other studies is similarly wide (Steinbach et 
al. 2014; Segev et al. 2013). Potential explanations include: differing severity of 
tubular injury between dogs, or presence of neutrophil origin NGAL. In humans, 
correlation between magnitude of uNGAL increase and mortality suggests that 
greater increases are associated with more severe injury
 
(Haase et al. 2009). 
Histology revealed variation in the degree of tubular damage induced between 
dogs, and this may account for some variation in the magnitude of uNGAL change 
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between individual dogs. The reason for differing severity of tubular damage 
between dogs was unclear. Possibly, despite attempts to produce a standardised I-R 
model, degree of shock induced in each dog differed and may have resulted in 
differences in renal hypoperfusion. Severe shock (the point at which anaerobic 
metabolism occurs due to mismatch between oxygen delivery and consumption) 
has been shown to occur at OER > 0.5 during various types of shock in 
anaesthetised dogs
 
(Cilley et al. 1989; Samsel et al. 1988; Gutierrez et al. 1986). In 
the current study, six dogs had an OER > 0.5 after haemorrhage, while one had an 
OER of 0.44. Furthermore, it is possible the severity of shock was not 
accurately quantified in this study due to measurement of central venous 
oxygen rather than mixed venous oxygen. It is also important to point out that 
OER is measure of global oxygen delivery and without measuring renal blood flow 
we cannot determine whether changes in uNGAL and tubular damage were 
associated with variable changes in renal oxygen delivery.  
Another potential source of variation may be an extra–renal source of NGAL such 
as neutrophils (Smertka & Chudek 2012; Mori & Nakao 2007; Lippi & Cervellin 
2012). Elevated uNGAL has been detected in non-azotaemic dogs with pyuria, 
presumably due to increased presence of neutrophils in the urinary tract (Daure et 
al. 2013). Human neutrophils produce a different molecular form of NGAL 
compared to the renal form (Lippi & Cervellin 2012; Daure et al. 2013; Cai et al. 
2010). Although ELISAs that distinguish between different molecular forms of 
human NGAL are available, canine NGAL ELISAs are currently unable to make 
this discrimination
 
(Bangert et al. 2012). Pyuria is unlikely to explain uNGAL 
variation in the current study, as only one dog had neutrophils in its urine and 
uNGAL was not higher than the other dogs. 
The current study demonstrated a small increase in SCr from baseline after 
hypotension and reperfusion. The International Renal Interest Society AKI grading 
 99 
 
 
 
system defines AKI Grade I and Grade II as a non-azotaemic (<140 µmol L
-1
) or 
mildly azotemic (141-220 µmol L
-1
) patient with progressive increase in SCr of 
>26.4 umol L
-1
 within 48 hours (Cowgill & Langston 2011). Using this system, all 
dogs would have been assigned as Grade II from T1 onwards. However, this 
grading system defines azotaemia as SCr > 140 µmol L
-1
, and the reference interval 
for SCr is higher in greyhounds than other canine breeds, thus IRIS may not be an 
appropriate grading system for this breed. Indeed, peak SCr during the study was 
above the normal reference interval for greyhounds in only three dogs
 
(Zaldivar-
Lopez et al. 2011). Significant SCr increases are generally not observed until the 
maintenance phase of AKI, when functional changes such as altered glomerular 
filtration rate become apparent, so it is more likely that the small increases in SCr 
in our dogs occurred due to pre-renal changes
 
(Basile et al. 2012).  This is 
suggested by the finding that increased SCr was evident immediately following 
hypotension (T1) and did not increase further during reperfusion. As change in 
uNGAL represents structural change to the kidney, it would not be expected to 
increase in purely pre-renal AKI, potentially making it a more sensitive marker of 
kidney damage than SCr. 
A limitation of our study is that uNGAL was measured for only three hours 
following I-R, so we were unable to report whether the dogs would have 
progressed to the maintenance phase of AKI.  The fold increase in uNGAL 
observed in our study was similar to that seen within a few hours of ischaemic 
injury in adult humans who progressed to the maintenance stage of AKI
 
(Wagener 
et al. 2006). The decrease in mean uNGAL at T4 following its initial peak at T2 
and T3 might suggest that the AKI induced by our model was minor and reversible, 
although it could represent a similar trend observed in human studies whereby an 
early rise in uNGAL is followed by a lesser yet sustained increase
 
(Mishra et al. 
2005). Canine clinical studies performed over a longer timeframe are required to 
clarify the relevance of the temporal change observed in the current study. 
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The finding that uNGAL was significantly elevated from baseline within two hours 
of reperfusion in a clinically relevant model of renal I-R injury provides 
encouragement for the use of uNGAL as an early biomarker for AKI in dogs.  
However, given the potential for baseline variation and differing magnitude of 
change between individual dogs, further work is required to clarify the usefulness 
of this marker in clinical practice. 
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FIGURE 
 
Figure 4.1 Mean arterial pressure recorded every five minutes for seven individual 
greyhound dogs that underwent a haemorrhagic shock model of ischaemia-
reperfusion acute kidney injury. Study design: instrumentation, 0 – 60 minutes; 
ischaemic phase, 60 – 120 minutes; reperfusion phase, 120 – 300 minutes. 
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TABLES 
 
Table 4.1 Formulae for calculated variables determined in seven greyhounds undergoing a haemorrhagic shock model of renal ischaemia and reperfusion. 
Body surface area calculation has previously been published for use in dogs (Rosenthal 1995). 
Calculated variable Formula 
BSA (m
2
) 10.1 x (bodyweight in grams
2/3
) x 10
-4 
Cardiac index (L minute
-1
 (m
2
)
-1
) Qt ÷ BSA 
CaO2 (mL L
-1
) (1.36 x SaO2 x Hb) + (0.003 x PaO2) x 10 
DO2I (mLO2 minute
-1
 (m
2
)
-1
) Cardiac index x CaO2 
CcvO2 (mL L
-1
) (1.36 x ScvO2 x Hb) + (0.003 x PcvO2) x 10 
VO2I (mLO2 minute
-1
 (m
2
)
-1
) Cardiac index x (CaO2 – CcvO2) 
 
OER VO2I ÷ DO2I 
UNCR uNGAL (ng mL
-1
) ÷ urine creatinine concentration (g/L) 
 
BSA, body surface area; Qt, cardiac output; CaO2, arterial oxygen content; DO2I, oxygen delivery index; CcvO2, central venous oxygen content; ; 
OER, oxygen extraction ratio; VO2I, oxygen consumption index; uNGAL, urine neutrophil gelatinase-associated lipocalin concentration; UNCR, 
uNGAL: urine creatinine ratio 
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Table 4.2 Indices of cardiovascular and urinary function in seven anaesthetised greyhound dogs before haemorrhage (T0), after 60 minutes of haemorrhagic 
(ischaemic phase) 40 mmHg (T1) and 1 hour (T2), 2 hours (T3) and 3 hours (T4) after fluid resuscitation (reperfusion phase). At T0 and T1, urine neutrophil 
gelatinase-associated lipocalin concentration (uNGAL) from one dog was considerably higher than of other dogs, consequently statistical analysis was 
performed with all seven dogs, and also without data from this dog. Values are mean (95% confidence interval). n, number of dogs; UNCR, urine NGAL: 
urine creatinine ratio. *Significantly different from T0 (p < 0.05)  
Variable Time points 
T0 T1 T2 T3 T4 
Mean arterial pressure (mmHg) 65 (60 – 69) 38 (36 – 41) 73 (67 – 79) 69 (64 – 73) 68 (64 – 72) 
Oxygen extraction ratio 0.15 (0.10 – 0.19) 0.54 (0.48 – 0.60) 0.22 (0.15 – 0.28) 0.21 (0.16 – 0.26) 0.24 (0.19 – 0.29) 
Urine output (mL kg
-1
 hour
-1
)  0.2 (0.2 – 0.3) 0.4 (0 – 0.8) 1.4 (1.0 – 1.8) 1.1 (0.5 – 1.6) 
Serum creatinine concentration (μmol L-1) 134 (116 – 153) 172 (156 – 188) 185 (167 – 203) 178 (164 – 193) 169 (147 – 191) 
uNGAL (ng mL
-1
) 12.1 (0 – 30.6) 11.0 (0 – 26.3) 62.9 (9.74 - 116.0) 122.0* (64.1 – 180.0) 91.7* (39.6 – 143.9) 
uNGAL (ng mL
-1
) (n=6) 4.6 (3.9 – 5.2) 4.7 (2.9 – 6.6) 55.0 (0 – 116.6) 125.9* (54.8 – 196.9) 32.5* (32.5 – 159.5) 
UNCR 4.84 (0 – 11.01) 2.86 (0 – 6.44) 41.73 (0 - 98.5) 71.34* (42.1 – 100.5) 41.35 (15.2 – 67.5) 
UNCR (n=6) 2.38 (0 – 5.51) 1.27 (0 – 2.86) 35.87 (0 – 104.1) 71.0* (34.7 – 107.2) 43.3 (11.4 – 78.3) 
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Table 4.3 Average number of injured renal tubules per 20X field alongside fold increase of urine neutrophil gelatinase-associated lipocalin concentration 
(uNGAL) and urine NGAL:creatinine ratio (UNCR) for seven greyhound dogs anaesthetized with isoflurane and subjected to 60 minutes of haemorrhage 
shock (ischaemic phase) and 3 hours of reperfusion. Dogs are listed in order of descending severity of tubular injury. T3, 2 hours of reperfusion; T4, 3 hours 
of reperfusion 
  Time interval 
 T3  T4 
Dog Average number of injured tubules 
per 20X field 
uNGAL fold change UNCR fold change uNGAL fold change UNCR fold change 
B 3.95 29.2 82.6 23.2 51.2 
D 3.85 32.9 66.1 33.4 52.5 
G 3.65 16.4 22.8 8.7 7.0 
A 3.00 57.4 78.9 39.2 38.6 
C 1.55 9.9 32.0 4.7 17.2 
E 1.30 21.1 6.4 16.5 3.2 
F 1.05 1.7 3.9 1.2 1.6 
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CHAPTER 5 - GENERAL DISCUSSION 
This series of studies developed a clinically relevant model of I-R using 
experimental haemorrhage and fluid resuscitation, which was subsequently used to 
investigate the temporal changes in uNGAL during early AKI. A pilot study 
confirmed that when mean arterial pressure was maintained below 40 mm Hg for 60 
minutes, the model successfully produced acute renal tubular injury within two hours 
of reperfusion, as confirmed by histology. The pilot study also allowed 
determination of appropriate urine sample dilution when using a commercially 
available canine NGAL ELISA, and ruled out potential assay interference by 
synthetic colloid fluid administration during reperfusion. Subsequently the model 
was used to investigate early changes in uNGAL and UNCR associated with I-R 
AKI. The results of the final component of the study confirmed significant increases 
in uNGAL and UNCR from baseline within two hours of reperfusion. 
To determine the changes in uNGAL during the early stages of I-R tubular injury in 
dogs, a standardised clinically relevant model of renal I-R was first developed 
(Chapter 2). Previously, most experimental animal studies investigating I-R AKI 
have utilised occlusion of renal vasculature to produce ischaemia (Mishra et al. 
2003; Mori et al. 2005). However, complete renal vascular occlusion is uncommon 
during veterinary surgery and so the clinical relevance of these models is limited 
(Moore et al. 2012). As well as tissue ischaemia subsequent to reduced renal 
perfusion, there are many other mechanisms involved in the development of tubular 
injury during hypoperfusion-related I-R. Altered renal vascular resistance and pro-
inflammatory effects subsequent to activation of the sympathetic nervous system, 
and altered plasma levels of hormones and cytokines, exacerbate tubular damage 
during I-R AKI (Chintala & Jandhyala 1990; Li et al. 2012). The model of I-R AKI 
developed in the pilot study was designed to simulate renal hypoperfusion and 
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reperfusion secondary to severe intra-operative haemorrhage and subsequent fluid 
resuscitation. Based on work from the pilot study it was identified that maintaining 
MAP below 40 mmHg for 60 minutes followed by two hours reperfusion was 
sufficient to cause tubular damage which was confirmed histologically. The pilot 
study also confirms that the histological changes associated with the I-R are easily 
distinguished from changes associated only with autolysis. The histological changes 
seen following I-R in this pilot study were consistent with those identified in other 
species (Devarajan 2010), supporting the ability of the model to produce early 
tubular injury.  
The pilot study indicated the magnitude of change in uNGAL to be expected 
following I-R, and thus allowed determination of appropriate sample dilutions in 
order to obtain uNGAL within the dynamic range of the ELISA. Initial measurement 
using the manufacturer’s recommended dilution of 1 in 100 for urine samples was 
found to be insufficient to produce concentrations within the dynamic range of the 
assay. Subsequent measurement revealed that a 1 in 1000 dilution was required to 
accurately determine the uNGAL due to the high uNGAL witnessed during 
reperfusion. 
Serum NGAL concentration measured following I-R was not different to baseline 
measurements in the pilot study. Findings of veterinary clinical studies investigating 
the use of serum or plasma NGAL concentration to diagnose AKI are mixed. One 
study found that while uNGAL increases within 12 hours of anaesthesia in dogs that 
develop AKI post-operatively, sNGAL does not change (Lee et al. 2012). However, 
plasma NGAL concentration has been shown to become elevated in dogs diagnosed 
with AKI compared to controls, and furthermore it is suggested that plasma NGAL 
concentration may be helpful to differentiate AKI from chronic kidney disease 
(Steinbach et al. 2014). Further work is required to establish the use of sNGAL for 
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diagnosis of AKI in dogs. Given the finding that sNGAL did not increase following 
I-R during our pilot study, we limited further investigation to uNGAL only. 
During the performance of the pilot study, it was observed that there was large 
variation in measured uNGAL between individual dogs. In two dogs, uNGAL 
remained below the dynamic range of the assay during reperfusion, despite 
histopathological evidence of AKI. One possible reason for this may have been the 
presence of interfering substances within the urine. When establishing an 
immunoassay for use in a scientific study it is important to rule out any measurement 
bias that may be introduced by the presence of interfering substances within the 
sample to be tested. Interfering substances found in the sample matrix can affect the 
performance of an immunoassay resulting in falsely high or low measurements of 
analyte concentration (Tate & Ward 2004). Commercially available ELISAs, such as 
the one used in this study, undergo rigorous testing by the manufacturer to ensure 
there is no interference from many commonly recognized endogenous matrix 
substances; however some exogenous substances unique to a particular clinical 
setting or situation may not previously have been investigated. During performance 
of the pilot study, the urine was observed to become increasingly viscous after 
administration of the synthetic colloids. The authors hypothesised that the small 
molecular weight components of the synthetic colloid solutions used during fluid 
resuscitation were being excreted in large quantities during reperfusion and the 
presence of these molecules in the urine may have interfered with the performance of 
the ELISA. In order to test this hypothesis, difference in spectrophotometry 
measurement of mean absorbance between urine, colloid solutions and empty well 
was investigated, and linearity of the assay at serial dilutions of a standard solution 
containing a known concentration of NGAL was assessed. No evidence of 
significant interference on the performance of the assay was found by 4% 
succinylated gelatin. The 6% hydroxyethyl starch produced some variation in 
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spectrophotometric measurement; however this is not expected to have significant 
impact on assay performance. Subsequently (Chapter 4) the use of synthetic colloids 
during reperfusion was standardised to 4% succinylated gelatin at a total volume 
administered of 20 – 30 mL kg-1.  
As the colloid solutions were not found to be a likely cause of assay interference, the 
reason for variation in uNGAL during Chapter 2 is not clear. It was postulated that 
degradation of samples during storage may have contributed to variable results, as 
some samples were stored at room temperature for up to one hour prior to 
processing. Previous work has shown that human NGAL is sufficiently stable in 
urine stored at room temperature for up to 24 hours, and also at 4
o
C for up to seven 
days with < 2% change in NGAL concentration between days one and seven (Han et 
al. 2009; Grenier et al. 2010). For longer term storage (months) human urine 
samples are required to be stored at -75
o
C as those stored at -20
o
C showed 
significant decrease in their NGAL concentration (Bennett et al. 2008; Han et al. 
2009). To date, there are no published studies investigating the stability of canine 
uNGAL at different storage temperatures. A standardised storage method was 
subsequently used in the final study whereby urine samples were immediately 
centrifuged and aliquots of supernatant placed on ice for a maximum of four hours 
prior to storage at -80
o
C. When this standardised processing was performed (Chapter 
4), all dogs showed increases in uNGAL. This suggests that handling of the samples 
may be important. Further studies comparing effects of storage at room temperature 
and refrigeration on canine uNGAL are required to determine appropriate sample 
handling for accurate determination of uNGAL and concentrations of other urinary 
biomarkers in dogs, particularly if these biomarkers are to become clinically useful.  
Results of Chapter 4 confirmed that during I-R AKI, uNGAL and UNCR increase 
from baseline within two hours of reperfusion, by an average of 28-fold and 47-fold, 
respectively. These findings are consistent with those from rodent vascular occlusion 
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models and human clinical studies. Increased uNGAL within two hours of acute 
tubular ischaemia occurs in experimental studies using renal vascular clamping 
models of ischaemic AKI in rodents
 
(Mishra et al. 2003). Following 
cardiopulmonary bypass, uNGAL increased by almost 100-fold in children within 
two hours, and by 40-fold in adults within one hour of surgery (Mishra et al. 2005; 
Wagener et al. 2006). In this study, variation in baseline uNGAL was encountered, 
with uNGAL in one dog more than tenfold higher than that of all other dogs. Wide 
variation in baseline uNGAL for healthy people has created difficulty in determining 
a reference interval (Clerico et al. 2012; Smertka & Chudek 2012). Many veterinary 
patients diagnosed with AKI present to a veterinarian after injury has occurred (e.g. 
snake envenomation, trauma, urinary tract obstruction) and so it is not possible to 
obtain baseline measurements. Despite statistically significance differences in mean 
(or median) uNGAL between dogs with AKI and controls in previous veterinary 
studies, when the spread of data is taken into account many of the individual uNGAL 
measurements from dogs with AKI and controls dogs appear to over-lap (Lee et al. 
2012; Hsu et al. 2014; Steinbach et al. 2014). When the variation in baseline 
uNGAL measurements detected in Chapter 4 are taken into account, these findings 
indicate that use of a single uNGAL measurement, after injury has occurred, may be 
limited for the diagnosis of AKI in dogs.  
Less variation between individual dogs at baseline was encountered when UNCR 
was calculated; this may indicate that some variation can be accounted for by 
differing urine concentration between individual dogs. It has previously been 
suggested that the UNCR, rather than total uNGAL, should be reported in studies 
investigating the use of NGAL as a biomarker for AKI (Grenier et al. 2010). The 
rationale for this is that by normalising to urine creatinine concentration bias that 
might be introduced by changes in urine concentration and flow during steady state 
GFR are removed (Goldstein 2010). The findings of this study suggest that during 
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periods of stable GFR (e.g. baseline), UNCR may a more appropriate measurement 
than uNGAL in order to reduce bias introduced by differing hydration status and 
urine flow rate between patients. However, use of UNCR rather than uNGAL during 
I-R may be less appropriate because normalisation to urine creatinine assumes a 
constant creatinine excretion rate within an individual over time (Waikar et al. 2010; 
De Loor et al. 2013). This was supported by similar variability in UNCR and 
uNGAL measured after haemorrhage and reperfusion. Regardless, both uNGAL and 
UNCR were significantly increased from baseline by two hours of reperfusion, 
indicating that at this time interval the two could be used interchangeably. By three 
hours of reperfusion (T4) the increase in UNCR was no longer significant, while the 
increase in uNGAL remained significant. A reduction in biomarker: creatinine ratio 
is likely during the very early stages of AKI regardless of whether concentration of 
the biomarker itself is elevated, simply due to increased urinary excretion of 
creatinine (Waikar et al. 2010; Ralib et al. 2012). During the early stages of AKI, 
GFR changes rapidly leading to unstable urinary excretion of creatinine; in addition 
back-leak of creatinine across injured tubules may occur (Waikar et al. 2010). Given 
the findings of the current study it is tempting to agree with authors who suggest 
that, given the large fold changes in uNGAL that have been shown to occur during 
AKI, it is unnecessary, and potentially misleading, to normalise to urine creatinine in 
these circumstances (Mori & Nakao 2007). 
The wide variation in the magnitude of change of uNGAL and UNCR between 
individual dogs following I-R may be explained by different levels of induced 
tubular injury, despite use of a standardised model, or may represent different 
physiological responses of individual dogs during AKI. However, this study was not 
designed to investigate baseline variability in uNGAL, or to investigate whether 
differing severity of renal I-R injury correlated with the magnitude of change to 
uNGAL, UNCR or histopathology changes. Further study in these areas is required 
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to establish the usefulness in these biomarkers for predicting severity of injury and 
possible outcome in dogs suffering AKI. 
This study identified a slight reduction in uNGAL at the final sample time (T4), 
following a peak at T3. This finding might suggest that the AKI induced by this 
model was minor and reversible, alternatively it could represent a similar trend to 
that observed in human studies whereby an early rise in uNGAL is followed by a 
lesser yet sustained increase
 
(Mishra et al. 2005). The fold increase in uNGAL 
observed in our study was similar to that seen within a few hours of ischaemic injury 
in adult humans who progressed to the maintenance stage of AKI
 
(Wagener et al. 
2006). The studies outlined in this thesis were limited to the investigation of uNGAL 
during only the very early stages of I-R AKI, and investigations into longer term 
change in concentration of the biomarker in dogs are required in order to clarify the 
relevance of the temporal change observed. 
CONCLUSIONS  
 
The results of this study show that the clinically relevant model of I-R developed in 
Chapter 2 consistently produced acute tubular injury. Using this model we confirmed 
that uNGAL is significantly elevated from baseline within two hours of reperfusion. 
This provides encouragement for its use as a biomarker for AKI in dogs.  However, 
given the potential for baseline variation and differing magnitude of change between 
individual dogs; there is scope for further investigation.  Further work using a larger 
cohort of dogs is required to determine if a reference range can be established for 
NGAL. In addition, the effects of storage at different temperatures, and for varying 
duration, on the stability of NGAL in canine urine should be investigated.  
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Given the variation in baseline measurements and magnitude of change of 
uNGAL during a standardised model of I-R AKI, it may be suggested that this 
biomarker alone is not capable of fulfilling all the required qualities of an ‘ideal’ 
biomarker for AKI (Cobrin et al. 2013). Whilst NGAL is likely to play an important 
role in the diagnosis of AKI both in the research and clinical setting in the future, a 
panel of urinary and serum biomarkers such as NGAL, with or without traditional 
markers such as sCr, may become the most useful and reliable method of AKI 
diagnosis and grading (Lisowska-Myjak 2010; Cobrin et al. 2013).  
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APPENDIX – RENAL HISTOPATHOLOGY 
IMAGES 
Figure A.1 Examples of vacuolar degeneration and attenuated tubular epithelium in 
photomicrographs of kidney obtained from greyhounds that underwent a 
haemorrhagic shock model of ischaemia (60 minutes) and reperfusion (three hours). 
(a) Dog D; vacuolar degeneration of proximal tubular epithelial cells (arrows), an 
adjacent tubule (*) is lined by markedly attenuated epithelium. (b) Dog F; vacuolar 
degeneration of proximal tubular epithelial cells (arrows), the adjacent glomerulus 
(*) is within normal limits. Periodic acid-Schiff staining, magnification 400x. 
(a) 
  
 (b) 
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Figure A.2 Examples of detached necrotic tubular cells in photomicrographs of 
kidney obtained from greyhounds that underwent a haemorrhagic shock model of 
ischaemia (60 minutes) and reperfusion (three hours). Proximal tubules contain 
sloughed epithelial cells (arrows). (a) Dog B (b) Dog D (c) Dog F. Periodic acid-
Schiff staining, magnification 400x 
(a) 
 
 
(b) 
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